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Neuronal progenitor cell-NT2/D1 has been used as a cell model to characterize 
the functions of transcription factor-Nurr1 and mitotic regulator-Pin1 during neuron 
development. Mature mammalian neurons are incapable of cell division and cannot, 
with the exception of olfactory neurons, be generated from stem cells in the adult 
nervous system. Embryonic carcinoma cell lines satisfy some of the above criteria. 
Before exposure to RA, these mitotically active NT2 cells express several markers 
typical for neural epithelial cells and neural progenitors committed to neuronal cell 
fate. After exposure to RA and mitotic inhibitors, these NT2 cells differentiate into 
post-mitotic neuron-like cells resembling committed CNS neuronal precursors.  
Nurr1, a transcription factor belonging to the nuclear receptor family, is essential 
for the generation of midbrain dopamine (DA) cells during embryonic development 
and it continues to be expressed in adult DA neurons. However, the mechanism by 
which Nurr1 promotes dopamine cell differentiation has remained unknown. In this 
study, I have used a neuronal progenitor cell line (NT2/D1), which retains some stem 
cell characteristics and is capable only of terminal differentiation into neurons, to 
analyze the function of Nurr1 in dopamine cell development. With regard to the 
function of Nurr1 in brain development, deletion of the Nurr1 gene results in the loss 
of ventral midbrain DA neurons by their time of birth, at embryonic day 11.5. 
Overexpression of Nurr1 in a neural stem cell line (c17.2), which does not 
spontaneously generate TH-positive cells, resulted in cells that upon removal of 
mitogens predominantly differentiated into neurons, but less than 1% were 
TH-positive. Notably, other Nurr1-overexpressed neural stem cells or embryonic stem 
cells give rise to glial cells that could then inadvertently participate in the 
 x
differentiation of DA precursors in vitro. In agreement with a key role of RXR ligands 
in the development of DA neurons, it has been previously reported that RXR agonists 
can enhance the DA differentiation of Nurr1-overexpressing neural stem cells.  
The present study described here was also to explore the function of Pin1, which 
is a conserved isomerase that is diversely involved in various biological processes and 
pathological conditions, in neuronal cell differentiation or neuron development 
together with Nurr1, which is an important gene in dopaminergic neuron development; 
and the standard functions of Nurr1 have been characterized. The results 
demonstrated that Nurr1 can induce cell cycle arrest and the cells differentiated with 
distinct neuronal morphology after all-trans retinoic acid treatment. It was also 
indicated that up-regulation of some dopaminergic neuron markers (e.g. TH, DAT and 
D2DR) while down-regulation of CyclinD1-Cdk6 activity marks the key events in the 
early stages of dopaminergic neuron differentiation. Furthermore, Pin1, a highly 
conserved isomerase, which directly interacts with regulators of the cell cycle, was 
also found to be involved in neuronal progenitor cell differentiation. Finally, the direct 
interaction between Nurr1 and Pin1 was identified and the possible mechanism 
whereby Pin1 affects the progression of cell cycle and cell differentiation by 
disrupting the signal transduction downstream of Nurr1-related pathway in 


















1.1 A short review of Parkinson’s disease 
Parkinson’s disease (PD) is a progressive neurodegenerative movement disorder 
that is estimated to affect approximately 1% of the population older than 65 years of 
age (Lang and Lozano 1998a & 1998b). Clinically, most patients present with the 
cardinal symptoms of bradykinesia, resting tremor, rigidity, and postural instability. A 
number of patients also suffer from autonomic, cognitive, and psychiatric 
disturbances. The major symptoms of PD result from the profound and selective loss 
of dopaminergic (DA) neurons in the substantia nigra pars compacta (SNc), but there 
is wider spread neuropathology with the SNc becoming involved later toward the 
middle stages of the disease (Braak et al. 2003). The pathological hallmarks of PD are 
round eosinophilic intracytoplasmic proteinaceous inclusions termed Lewy bodies 
(LBs) and dystrophic neuritis (Lewy neuritis) present in surviving neurons (Forno 
1996).  
PD is primarily a sporadic disorder and its specific etiology is not fully 
understood, but important new insights have recently been provided through studying 
the genetics, epidemiology, and neuropathology of PD, in addition to the development 
of new experimental models. Until recently, PD had been considered the prototypical 
non-genetic disorder. In the past seven years, the identification of distinct genetic loci 
responsible for rare Mendelian forms of PD has challenged this view and has 
provided us with vital clues to understanding the molecular pathogenesis of the more 
common sporadic forms of this disease. There genetic advances have revolutionized 
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the way we think about PD and have opened up new and exciting areas of research. 
Despite such advances, much recent research has continued to focus on the 
contribution of non-genetic or environmental factors to the development of sporadic 
forms of PD.  
 
1.2 Genetic contributions to Parkinson’s disease 
1.2.1 Gene expression profile in dopaminergic neuron differentiation 
Midbrain dopamine (DA) neurons comprise a heterogeneous group of neurons 
that control elementary brain functions. First, they are involved in the control of 
movement; hence their prime role in Parkinson’s disease. Second, they are part of 
circuits controlling mood and reward, and thereby behavior. These two functions of 
midbrain DA systems are partly distinguished anatomically in the nigrostriatal 
systems (movement) and the mesolimbic system (behavior). 
Despite differentiation in anatomy and functions, all midbrain DA systems share 
the dopaminergic transmission machinery to communicate with postsynaptic elements 
of the networks.  They are part of dopaminergic transmission which requires 
coordinated expression of specific gene products in order to synthesize and recycle 
the transmitter, to receive and control the chemical signal, and to transduce this into 
relevant cellular responses. Thus, midbrain neurons, despite their heterogeneous 
functions, have in common the transcriptional control to activate the gene sets 
necessary for dopaminergic transmission. 
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The distinction between functionally different groups of midbrain DA neurons is 
made at the level of the anatomy of cell bodies and the connectivity of axonal 
efferents with postsynaptic structures. DA signaling by substantia nigra (SN) neurons 
innervating the striatum modifies brain circuits controlling movement, while 
behavioral responses are triggered by ventral tegmental (VTA) DA neurons in the 
nucleus accumbens and other limbic areas. Thus, transcriptional control of genes 
involved in migration and axonal guidance is likely different from those involved in 
determination of the DA identity and is possibly variable between populations of 
midbrain DA neurons.  
  
1.2.1.1 Transcriptional control of dopamine neuron development 
1.2.1.1.1 Preparation of the early midbrain 
The mesencephalic DA neurons are generated in the immediate vicinity of two 
organizing centers, the mid/hindbrain boundary (MHB) and the floor plate, a 
specialized cell type that lies along the CNS ventral midline. Before the expression of 
DA-specific markers, ventral midbrain markers are present in these cells. Among the 
earliest markers of the regions are the homeobox genes engrailed-1 (En1), engrailed-2 
(En2), Pax2 and Pax5, and the growth factor Wnt1. In vertebrate embryo, the 
expression of En1 and En2 is maintained by the expression of the signaling molecule 
Wnt1 (Danielian et al. 1996). Another homeobox gene implicated in the early 
specification of the ventral midbrain is Lmx1b. This gene is expressed at E7.5 of 
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vertebrate embryo in the ventral midbrain and diencephalons, and remains expressed 
in the adult in brain structures derived from these areas, including midbrain DA 
neurons (Smidt et al., 2000). 
The specific sign of the birth of midbrain DA neurons is the expression of 
tyrosine hydroxylase (TH), the rate-limiting enzyme of DA synthesis and a frequently 
used marker for DA neurons, can be detected from approximately embryonic day E11 
in the mouse midbrain. TH initially appears rostrally of the MHB and close to the 
ventral midline (Wurst et al., 2001). Several studies show that proliferating DA 
progenitor cells are specified well before E11 by the combined actions of two secreted 
signaling proteins, sonic hedgehog (Shh) and fibroblast growth factor 8 (Fgf8) (Hynes 
et al., 1999;  Rosenthal et al., 1998). Remarkably, only one marker specific for the 
proliferating DA progenitor cells has been reported. Aldh1, an aldehyde 
dehydrogenase capable of metabolizing retinal dehyde into retinoic acid (Lindahl et 
al., 1984), is expressed in the ventral midbrain already at E9.5 (Wallen et al., 1999). 
Its expression is confined to proliferating cells of the ventral midbrain neuroepithelial, 
but it continues to be expressed after cells have stopped proliferating and is later 
co-localized with postmitotic markers including TH (Wallen et al., 2001).  
 
1.2.1.1.2 Postmitotic differentiation 
The first postmitotic differentiating DA cells appear at approximately E10-10.5 in 
the mouse (Lauder et al., 1974). The cessation of proliferation is followed by 
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up-regulation of general neuronal and specific dopaminergic markers such TH. Newly 
formed neurons migrate into medial and lateral positions, and they also begin to 
initiate target innervation. Several transcription factors influencing these 
developmental processes have recently been characterized. These factors include the 
nuclear receptor Nurr1 and the homeodomain transcription factors Lmx1b, Pitx3, and 
En1/En2. The following stages of dopaminergic neuron development can be roughly 
divided into two molecular signaling pathways: (1) the homeobox pathway, and (2) 
the Nurr1 pathway.  
 
1.2.1.1.3 The homeobox pathway-specification of architecture and connectivity  
As yet, four homeobox genes have been shown to be expressed in DA neurons: 
En1, En2, Lmx1b, and Ptx3. Ptx3 differs from the others in both timing and space: 
Ptx3 is induced late, and its brain expression is confined to DA neurons. En1, En2, 
and Lmx1b are expressed in the ventral midbrain, well before induction of TH; their 
expression extends largely beyond DA progenitors (Joyner et al., 1996). 
In situ hybridization on mouse embryos from E8.5 to E16.5 showed the induction 
of Ptx3 expression with appearance of midbrain DA neurons. At E11.5, a small layer 
at the ventral surface of the mesencephalic flexure Ptx3. At E12.5, a complete field of 
TH-positive, Ptx3-positive neurons has been obtained. These Ptx3-positive cells are 
restricted to the marginal layer of the mesencephalic tegmentum. This group of about 
50 cells corresponds to the first TH-expressing cells in the developing rodent brain. At 
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later stages, the expression remains restricted to the midbrain DA system, and this 
association is conserved in adult rat brain and human SN tissue. This has also been 
demonstrated by 6-hydroxy DA lesions that take away all Ptx3-positive neurons 
(Smidt et al., 1997). Extra-neural Ptx3 expression is found in the developing skeletal 
muscle, in the tongue and in the developing eye lens (Semina et al., 1997).  
Lmx1b is a member of the LIM homeo-domain family and is an essential 
regulator of dorso-ventral patterning of the developing limbs. Lmx1b mutations evoke 
the nail-patella syndrome (Dreyer et al., 1998, Chen 1998). Neural Lmx1b expression 
starts already at E7.5. Early embryonic expression is extending anterior to the 
midbrain DA region into the ventral hypothalamic area and posterior in the dorsal 
hindbrain and the dorsal spinal cord. In the ventral midbrain, Lmx1b is expressed in 
midbrain DA neurons. Lmx1b expression is maintained in the adult SN and VTA of 
rodents and in the melanin-containing SN neurons of man (Smidt 2000). Engrailed 
genes also have an early (E8 onwards), regionally broad expression field in the 
midbrain and hindbrain (Joyner 1996). Interestingly, like Lmx1b, their expression is 
maintained in adult midbrain DA neurons. En1 is highly expressed in all adult 
midbrain DA neurons, and En2 is only a subset or is not detectable (Simon et al., 
2001).  
The intrinsic potential of the Lmx1b and En1/En2 genes as developmental 
regulators, together with the fact that these homeobox genes are expressed earlier than 
Nurr1, TH, and Ptx3, initially raised the hypothesis that Lmx1b and En genes may act 
genetically as upstream activators of these genes, in addition to preparing the ventral 
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midbrain for genesis and differentiation of the midbrain DA system. To validate this 
hypothesis Smidt M. et al. (2000) analyzed expression of TH, Ptx3, and Nurr1 in 
brain sections of homozygous Lmx1b knockout mice of stage E12.5, when the field of 
expression of TH and Ptx3 is first complete. Lmx1b-/- embryos contained TH-positive 
cells in the ventral tegmentum, but these cells did not express Ptx3, indicating that 
Ptx3 is not necessary for TH expression. En1-null mutants are indistinguishable from 
wild-type mice, except for a high expression of En2 in all midbrain DA neurons 
(Simon et al., 2001). In En1/En2-double-null mutants TH-positive neurons are 
initially generated but soon lost (Simon et al., 2001). A similar observation has been 
made in Lmx1b-null mutants. Apparently, Lmx1b and En1/En2 genes are each 
required for survival of midbrain DA neurons.  
To test the contribution of Ptx3 to the development of midbrain neurons, mice 
homozygous for a defective Ptx3 allele were analyzed. These mice are blind, due to 
the function of Ptx3 in eye development, but grow and breed normally. These mice 
contain TH-positive neurons in the midbrain, but the anatomical organization is 
altered in two ways. First, TH-positive neurons are absent in the SN, and second, a 
central cell group exists frontal to the VTA. The organization of TH neurons in the 
VTA appears normal. Correlating with this phenotype is the lack of innervation of the 
dorsal striatum, which receives input from the SN DA neurons in wild-type mice. The 
innervation of the nucleus accumbens and olfactory tubercle exists as in wild-type 
mice. This phenotype suggests that Ptx3 disrupts processes required for expansion of 
DA neurons from E11.5 onwards. These processes significantly affect neurons that 
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will form the SN—that is, neurons that need to migrate laterally from the 
mesencephalic flexure. Whether or not Ptx3 drives the survival, migration, or axonal 
path-finding of this subset of neurons still need to be established. 
 
1.2.1.1.4 The Nurr1 pathway-induction of the dopaminergic transmitter 
phenotype and survival 
Nurr1 is an orphan member of the nuclear hormone receptor super-family of 
transcription factors (Law 1992). Nurr1 has a relatively wide field of expression in the 
embryonic midbrain, covering the entire ventral region (Smidt 2000). Only a small 
proportion of Nurr1-expressing neurons overlap with the midbrain DA progenitor 
neurons. Thus, brain expression of Nurr1 is not uniquely linked to midbrain DA 
neurons, in contrast to the homeobox gene Ptx3. The onset of Nurr1 expression in 
midbrain DA neurons is at E10.5 in the mouse, just before the induction of TH and 
Ptx3 at E11.5 (Smidt et al., 1997, Zetterstrom et al., 1996, Zetterstrom et al., 1997). 
The expression of Nurr1 is maintained in the adult stage, albeit in a more limited 
pattern, but including the midbrain DA system. Multiple regions of the adult brain 
express Nurr1 (Saucedo-Cardenas et al., 1996; Xiao et al., 1996; Backman et al., 
1999). The Nurr1 protein may therefore serve developmental and regulatory functions 
that are not restricted to DA neurons. 
The function of Nurr1 in the brain has been addressed by the creation of 
null-mutant mice by three groups (Zetterstrom et al., 1997, Saucedo-Cardenas et al., 
1998, Castillo et al., 1998). Mice with a targeted deletion of the Nurr1 gene die soon 
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after birth. Analysis of the brain of these animals using such markers as Adh2, cRet, 
and TH showed that in the newborn animals no midbrain DA neurons are present. 
Although it was initially concluded that this is due to “agenesis” of midbrain DA 
neurons (Zetterstrom et al., 1997), several additional studies demonstrated a more 
refined role of Nurr1 in midbrain DA neurons. At E12.5 Nurr1-null mutants express 
other markers associated with midbrain DA neurons, including HNF3β, Ptx3, and 
Lmx1b, but fail to induce TH (Zetterstromo et al., 1996; Saucedo-Cardenas et al., 
1997). cRet expression was also found to be absent in the ventral midbrain of 
Nurr1-null mutants (Saucedo-Cardenas et al., 1997). These findings link Nurr1 to the 
growth factor glia-derived neurotrophic factor (GDNF), which promotes the survival 
of DA neurons (Beck 1995). 
The role of Nurr1 as the key factor in the determination of the dopaminergic 
phenotype of midbrain DA neurons has been extended by two significant findings. 
First, it was shown that Nurr1+/- mice display diminished DA levels, suggesting that 
TH activity, which is rate limiting in neurotransmitter synthesis, is strictly regulated 
by Nurr1 (Zetterstrom et al., 1996). Second, in humans a correlation between Nurr1 
and TH has been found in the age-related decrease of Nurr1 in the SN (Chu et al., 
2002). In cocaine addicts Nurr1 expression levels were decreased (Bannon 2002), but 
this finding has not been compared to levels of TH.  
The mechanism by which Nurr1 induces TH has not been elucidated. Although 
Nurr1 has a weak trans-activating potential on 5’-flanking regulatory regions of the 
TH gene in heterologous cell lines (Sakurada et al., 1999, Cazorla et al., 2000), this 
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finding cannot explain a total dependence of TH expression on Nurr1. Therefore, 
Nurr1 may engage unique cofactors in DA neurons. Moreover, differentiation of 
embryonic stem cells into DA-expressing neurons is enhanced by survival-promoting 
factors that upregulate Nurr1 and TH in parallel (Rolletschek et al., 2001). Also, 
stable expression of Nurr1 in embryonic stem cells enhances the differentiation in a 
TH-expressing neuronal phenotype (Xu et al., 2002). 
Recent data suggest that the function of Nurr1 in DA neurons is not cell 
autonomous. In contrast to observations in vivo, it has been observed that TH can be 
induced in cultured ventral midbrain tissue of Nurr1-/- mice. Cultured ventral midbrain 
of these animals contains normal numbers of TH neurons when dissected at E10.5 or 
E15.5. These displayed a failure to develop nerve fiber bundles (Tornqvist et al., 
2002). 
The developmental program of midbrain DA neurons in the Nurr1-/- animals does 
proceed, as illustrated by the proper induction of the midbrain DA-specific homeobox 
gene Ptx3 (Saucedo-Cardenas et al., 1998) and maintenance of Lmx1b (Smidt et al., 
2000). The perinatal survival of these Nurr1-/- midbrain DA neurons is not entirely 
clear, since there have been conflicting findings (Saucedo-Cardenas et al., 1998, Le et 
al., 1999, Wallen et al., 1999). Whether these cells are lost gradually or maintained 
postnatally may depend on secondary influences, such as, perhaps, genetic 
background of Nurr1-null mutants. 
Due to the above various findings, we have to speculate that the degeneration of 
the midbrain DA neurons in Nurr1-/- is not only due to the fact that there is no DA 
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synthesis because of the lack of TH, but also that other cellular functions of Nurr1 in 
survival mechanisms are involved. The absence of TH alone is probably not sufficient 
for the severe neuronal loss that is found in Nurr1-/-mice, since DA-deficient mice still 
form projections to the striatum (Zhou et al., 1999). This degeneration may be indirect. 
Possibly, the Nurr1-/- midbrain DA neurons cannot form or maintain the connections 
to their targets, and therefore the neurons degenerate, as is found after transection of 
the projecting axons. Alternatively, Nurr1 drives other downstream targets that are 
required for survival. The dependence of cRet, a component of the GDNF receptor, on 
Nurr1 may link Nurr1 to survival.  
In summary, the data obtained from Nurr1- and Lmx1b-null mutants lead to the 
differentiation of two genetic pathways that operate in parallel in developing midbrain 
DA neurons. One pathway links Nurr1 to the induction of TH. The function of this 
pathway is to specify the identity of the neurotransmitter that will be employed by 
these neurons. The other pathway positions Lmx1b upstream of Ptx3. It is not yet 
clear whether the En genes operate fully independently of this pathway or are part of 
it. Disruption of this pathway by deletion of Lmx1b leads to rapid loss of TH-positive 
neurons after E12.5. Since this is not the case when Ptx3 is inactivated, Lmx1b must 
attribute additional survival properties to developing midbrain DA neurons. It is 
remarkable to note that disruption of transcriptional factors in separate 
pathways-Nurr1, En1/En2 and Lmx1b-affects the survival of developing DA neurons. 
Perhaps, also the phenotype of Ptx3-null mutants will turn out to be caused by 
compromised survival. This suggests that the maintenance of DA neurons is delicately 
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dependent on the appropriate activity of multiple transcriptional cascades. This may 
render the midbrain DA neurons a cell prone to degenerate if transcriptional pathways 
are affected.  
 
1.2.2 Pin1 in neurodegenerative diseases 
Phosphorylation is one of the most widely utilized post-transcriptional 
modifications of proteins and occurs principally at serine, threonine, and tyrosine 
residues. A number of proteins belonging to unrelated families have been found to 
contain a common module, the WW domain, which was selected during evolution for 
its ability to recognize phosphorylation amino acids in a proline-rich context (Kay et 
al., 2000). Examples of the first type of WW domain-containing proteins are F-box 
proteins (Kipreos et al., 2000), whereas representative of the latter is the 
peptidyl-prolyl isomerase (PPIase) Pin1 (Lu 2000). PPIase are chaperone proteins 
with multiple functions, including protein assembly, folding, intracellular transport 
(Gothel and Marahiel, 1999; Kay, 1996; Rulten et al., 1999; Schiene and Fischer, 
2000), intracellular signaling, transcription, cell cycle progression, and apoptosis 
(Hunter 1998; Yaffe et al., 1997).  
Pin1 is an 18-kDa protein with a C-terminal PPIase domain and an N-terminal 
WW domain (Lu et al., 1996). The latter domain confers specificity to a motif 
containing a phosphorylated serine or threonine residue preceding a proline (Lu et al., 
1999) and thence Pin1 can catalyze the cis-trans isomerization of such peptidyl-prolyl 
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bonds (Stukenberg et al., 2001). Pin1 interacts specifically with, and regulates the 
activity of, a subset of mitotic and nuclear proteins in a phosphorylation-dependent 
manner (Shen et al., 1998). These targets include not only nuclear proteins involved 
in control of the cell cycle, transcription and DNA supercoiling, but also other 
non-nuclear targets with roles in apoptosis, endocytosis, translation and control of cell 
size, maintenance of the cytoskeleton, and neuronal function (Lu 2004). For example, 
in HeLa cells, Pin1 depletion causes mitotic arrest and apoptosis, while 
overexpression results in G2 phase arrest (Lu et al., 1996). Moreover, during DNA 
damage, Pin1 is required for maintaining cell-cycle checkpoints, protecting the cell 
from DNA-damaged-induced apoptosis (Wulf et al., 2002; Zheng et al., 2002). 
However, Pin1 can also accelerate apoptosis by enhancing proapoptotic genes (Zacchi 
et al., 2002). Nuzhat P. et al., (2001) has found that microtubule-targeting drugs can 
induce Bcl-2 phosphorylation and association with Pin1. Bcl-2 is a critical suppressor 
of apoptosis that is overproduced in many types of cancer. Phosphorylated Bcl-2 
protein was discovered to associate in M-phase-arrested cells with Pin1 during mitosis. 
In contrast, phosphorylation of Bcl-2 induced by microtubule-targeting drugs did not 
alter its ability to associate with Bcl-2, Bax, Bag1, or other Bcl-2-binding proteins. 
Since the region in Bcl-2 containing serine 70 and serine 87 represents a proline-rich 
loop that has been associated with auto-repression of its anti-apoptotic activity, the 
discovery of Pin1 interactions with phosphorylated Bcl-2 raises the possibility that 
Pin1 alters the conformation of Bcl-2 and thereby modulates its function in cells 
arrested with anti-microtubule drugs.  
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On the other hand, Liou et al. (2003) have provided a strong evidence that Pin1 
might play a more central neuron-protective role. They showed that there are a lower 
Pin1 levels in susceptible regions of normal human brain, with an inverse correlation 
between neuronal Pin1 and NFT content in affected areas of AD brain. In addition, 
aged Pin1 knockout mice had behavioral and motor deficits, neuronal loss, and 
accumulations of phosphorylated proteins, including filamentous tau with a 
tangle-like appearance. Furthermore, Thorpe J.R. et al. (2004) have shown that tau 
hyper-phosphorylation in the neuro-fibrillary tangles (NFTs) of Alzheimer’s disease is 
associated with redirection of the predominantly nuclear Pin1 to the cytoplasm and 
with Pin1 shortfalls throughout subcellular compartments. As nuclear Pin1 depletion 
causes apoptosis, shortfalls in regard to both nuclear and p-tau targets may contribute 
to neuronal dysfunction such as in frontotemporal dementias (FTDs) characterized by 
abnormal protein aggregates of tau and other cytoskeleton proteins. 
These discrepancies regarding Pin1 functions in neuronal and non-neuronal 
apoptosis might reflect the fact that, depending on the conditions of the cell type and 
the certain induction of apoptosis, Pin1 could play different roles to the events 
involved in apoptosis. Further studies are required to define the physiological and 




1.3 Other aspects of PD studies 
1.3.1 Cell cycle studies in neurodegenerative diseases 
Many hypotheses have been proposed to explain the etiology and pathogenesis of 
PD and related disorders. There is a growing body of the evidence that inappropriate 
activation of the cell cycle, especially mitotic events, may contribute to the 
hyper-phosphorylation of certain proteins and thereby play an important role in the 
development of the diseases. Recently, there is increasing evidence that proteins 
normally involved in the cell cycle can regulate neuronal-programmed cell death in 
dopamine neurons of the substantia nigra. Bassem F. et al. have demonstrated in two 
models of postnatal induced PCD, medial forebrain bundle axotomy, and intrastriatal 
6-OHDA lesion, that cell cycle markers for the G2 phase (cdc2) and the S phase 
(BrdU incorporation) are expressed, but the M-phase marker MPM2 is not (Bassem et 
al., 2003). These results raise the possibility that cell cycle regulatory proteins may 
play a role in the demise of dopaminergic neurons in Parkinson’s disease, in which 
programmed cell death has been postulated to play a role. As for Alzheimer’s disease, 
the expression of cdc2 in vulnerable neurons is accompanied by aberrant expression 
of cell cycle markers of the G1/S phase such as cyclin D1, Cdk4, PCNA, and cyclin B 
and of the M-phase marker MPM2 (Busser et al., 1998; Husseman et al., 2000; 
Vincent et al., 1997).  
There is especially a need to understand whether cell cycle markers are expressed 
in conjunction with PCD in normal, postmitotic, post-migratory neurons. Noticeably, 
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progression through different phases of the cell cycle is controlled by highly regulated 
sequential activation and inactivation of Cdks. Cdks belong to the family of 
Pro-directed kinases, which also include ERKs, JNKs and GSK-3β, that 
phosphorylate almost exclusively on Ser/Thr-Pro motifs (Morgan 1997). Moreover, 
an intriguing and common feature among many MPM2 antigens is that they are 
phosphorylated on multiple Ser/Thr residues clustered at the regulatory domain of 
molecules during mitosis. In addition, the above mentioned PPIase, Pin1, substrates 
are a defined subset of phosphorylated proteins, many of which are also recognized 
MPM2 antigens (Lu et al., 2002); and actually Pin1 and MPM2 recognize similar 
pSer/Thr-Pro-containing sequences (Yaffe et al., 1997). Together with the 
phosphorylation/de-phosphorylation of α-synuclein, we might propose that Pin1 
would regulate the conformational changes of α-synuclein aggregation in LBs by 
recruiting certain cell cycle markers such as Cdks; and whether Pin1 would help with 
the de-phosphorylation of α-synuclein under steady state conditions is also interesting 
and promising. 
Quite recently, there are some key findings about cell cycle markers in 
Parkinson’s disease. For example, Lee et al. (2003) investigated the effects of 
α-synuclein on the cell cycle in engineered PC12 cells expressing this protein 
conditionally. They found that overexpression of α-synuclein increases the levels of 
phosphorylated ERKs (extracellular signal-regulated kinases). As a result, cell cycle 
progression is altered to enrich the mitotically competent cell population. Meanwhile, 
they also found cyclin B immunoreactivity in LBs in cases with PD (Lee et al., 2003). 
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Moreover, Smith (2003) found that cyclin-dependent kinase 5 (CDK 5) is a mediator 
of dopaminergic neuron loss in a mouse model of Parkinson’s disease; and they also 
studied CDK inhibition strategies attenuate MPTP-induced hypolocomotion and 
markers of striatal function independent of striatal dopamine (Smith 2003).  
In summary, taking all these findings together, an attractive model of 
dopaminergic death is one in which cell cycle markers especially the CDKs act 
concertedly on multiple substrates, including cytoskeleton components and 
death-related signaling components. Therefore, it is important to elucidate any 
potential downstream targets as it relates to dopaminergic cell loss and the following 
questions are pivotal to address: (1) what is the functional relevance of CDKs in adult 
models of neurodegeneration, and (2) which CDKs participate in neuronal loss in 
vivo.  
 
1.3.2 Therapeutic strategies of PD-related neurodegenerative 
diseases 
1.3.2.1 General information  
Embryonic stem (ES) cells have been used to generate animal models of human 
disorders as well as to treat them with cell transplantation procedures. These cells 
have also been important for studying the mechanisms underlying cellular 
development. Several studies have used differentiated ES cells with 
dopamine-synthetic capacity to counteract deficits of this transmitter in animal models 
for Parkinson’s disease. PD is a condition characterized by the loss of ascending 
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dopaminergic fibers from the substantia nigra to the straitum (Kim et al., 2002; 
Nishimura et al., 2003). One potential goal of this approach is to replace lost 
dopaminergic neurons that form new, functional, synaptic connections between the 
substantia nigra and straitum. It would be important for these connections to regulate 
pre-synaptic dopaminergic processes homeostatically, especially given the permanent 
nature of the implantations. However, few studies have evaluated these processes 
carefully. This may underlie variations in the ability of different preparations of 
neuronally differentiated ES cells to survive and function in vivo. 
There are several procedures to differentiate ES cells into cells with neuronal 
properties; two have been best characterized for dopaminergic activity (Lee et al., 
2000; Kawasaki et al., 2000). One method using embryoid bodies and growth factors 
has been analyzed by several groups with respect to a variety of dopaminergic 
properties. These include tyrosine hydroxylase (TH) immunoreactivity and 
depolarization-induced DA releases (Lee et al., 2000). In vivo, Nurr1-overexpressed 
TH-positive cells showed neuronal electrophysiological properties and restored 
locomotor deficits associated with DA-deficiency when implanted into the striatum 
(Kim et al., 2002). However, in a preparation of CNS precursors involving 
Nurr1-induced dopaminergic differentiation, no behavioral improvement was seen 
after striatal implantation. This may have been attributable to their lower levels of 
dopamine release than was seen in mesencephalically derived precursors (Kim et al., 
2003) or perhaps to other pre-synaptic dopaminergic processes.  
There are also the similar gaps remain in the understanding of the second ES cell 
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differentiation protocol, which involves co-cultures with a calvaria-derived stromal 
cell line (PA6) (Kawasaki et al., 2000). This differentiation procedure may also 
provide a source of functional dopaminergic neurons based on the initial studies 
showing the expression of several dopaminergic markers including transmitter release. 
However, these differentiated cells have not been shown to promote behavioral 
deficits associated with Parkinsonism after implantation in vitro. Moreover, their 
survival post-implantation depends on factors that remain unclear, including whether 
injected as colonies or isolated neurons (Morizane et al., 2002).  
In summary, pre-synaptic DA homeostasis is a complex process regulated by at 
least four mechanisms: de novo transmitter synthesis for which the rate limiting 
enzyme is TH; transmitter storage in synaptic vesicles; depolarization-induced release 
of the transmitter; and high affinity reuptake of transmitter by a sodium-dependent 
transporter (DAT). Further, extracellular factors that affect dopaminergic function and 
synapse formation include trophic factors such as glial cell line-derived neurotrophic 
factor (GDNF), which increases dopaminergic arborization in the adult nigrostriatal 
pathway (Bowenkamp et al., 1995; Choi-Lundberg et al., 1997; Lin et al., 1993; 
Tomac et al., 1995) and which transiently increases the survival of embryonic 
dopamine neurons in transplanted neuron-spheres.  
 
1.3.2.2 A therapeutic cell model of Parkinson’s disease 
The human embryonal carcinoma cell lines NT2 /D1, clonally derived from 
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Tera-2, differentiate extensively in vitro when exposed to retinoic acid (Andrews, 
1984). Under specific culture conditions, it has been shown to give rise to neurons and 
glia, suggesting that NT2 precursors, similar to neural precursors, have unrestricted 
potential to generate progeny of two out of three major neural lineages (Pleasure et al., 
1992 and 1993). Before exposure to retinoic acid (RA), these mitotically active NT2 
cells express several markers typical for neural epithelial cells and neural progenitors 
committed to neuronal cell fate, including neuroepithelial intermediate filaments 
keratin and nestin (Lee et al., 1986), cell adhesion molecules NCAM and N-cadherin 
(Pleasure et al., 1993), epithelial cell surface antigen AUA1 and stage-specific 
embryonic antigen-3 (SSEA-3) (Andrews et al., 1984). After exposure to RA and 
mitotic inhibitors, these NT2 cells differentiate into post-mitotic, neuron-like cells 
resembling committed CNS neuronal precursors (Pleasure et al., 1992).  
Morphologically, NT2 neurons, like primary neurons, extend processes that form 
axon and dendrites (Pleasure et al., 1992). They express a variety of neuronal 
phenotypes typical for young and mature neurons, including III β-tubulin (TuJ1), 
microtubule-associated protein 2 (MAP-2) and neuro-filament (NF) protein, surface 
markers, such as neural cell adhesion molecule (NCAM) and growth-associated 
protein 43 (GAP-43) (Andrew et al., 1984; Pleasure et al., 1992). Their 
neurotransmitter profile in vitro includes cholinergic, catecholaminergic, GABAergic, 
and serotonergic phenotypes, along with appropriate neurotransmitter enzymes, such 
as choline acetyl-transferase (ChAT), glutamic acid decarboxylase (GAD), and 
tyrosine hydroxylase (TH). DA markers typical of ventral mesencephalic (VM) 
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neurons (TH, DAT, D2, AHD-2) were also detected immunocytochemically in 
cultured NT2 cells (Iacovitti et al., 1997; Sodja et al., 2002; Zigova et al., 2000).  
NT2 cells have been widely used to study neuronal differentiation and cell 
therapy strategies in neurodegenerative diseases. Trojanowski et al. (1993) firstly 
described the transplantation and survival of pure, postmitotic NT2 cells into the rat 
brain. They demonstrated that the grafted NT2 cells exhibited an asymmetric 
geometry as well as molecular polarity by 4 weeks post-transplant. Afterwards, they 
and other research groups did lots of trials of NT2 cells transfection and 
transplantation studies on rodent and human models (Trojanowski et al., 1997; 
Cheung et al., 1999; Lee et al., 2000; Schmeisser et al., 2002; Watson et al., 2003; 
Huang et al., 2005). Based on the above studies for years, Trojanowski and Lee et al. 
concluded that grafted NT2N cells could serve as a suitable platform for the delivery 
of exogenous proteins into the CNS for gene therapy of human nervous system 
diseases. 
 
1.4 Objective of current study 
The present study thus makes use of the neuronal progenitor cell-NT2/D1 to 
study the characteristics of the transcription factor-Nurr1 and peptidyl-prolyl cis-trans 
isomerase Pin1 and their influences during neuron development. These two genes 
were chosen based on literature search and personal interest, according to the research 
direction of Parkinson’s disease pathogenesis and possible stem cell therapy.  
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The detailed discourse of each of these two genes will be presented in the 
introduction of subsequent chapters (chapter III and IV, respectively). Each of this 
will include established information about these two genes, their expression and 
biological roles, respectively. 
In the present study, the cloning, expression pattern, distribution and biological 
functions of Nurr1 and Pin1 were each elucidated during the neuronal cell 
differentiation. Western blot, immunocytochemical assay and cell cycle analysis were 
carried out. The clones, containing Pin1-specific coding sequence have been 
generated via the one-step procedure of reverse transcription and polymerase chain 
reaction (RT-PCR) from total RNA of SH-SY5Y neuronal cells. And, the plasmid 
construct for mammalian expression, containing Nurr1-specific coding sequence has 
been sub-cloned from the cDNA of Nurr1, which was kindly provided by Dr. Thomas 
Perlmann (Karolinska Institute, Sweden). Thereafter, the resultant observations of the 
expression of both Nurr1 and Pin1 were then examined with respect to (i) their 
corresponding patterns as established in neuronal cell differentiation, and (ii) their 
respective characteristics in neuron developmental events, in particular for 
dopaminergic cell maturation. Possible mechanisms whereby Nurr1 and Pin1 
cooperate with each other in retinoic acid induced neuronal cell differentiation were 
explored and discussed.  
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2.1 Cell culture 
2.1.1 Cell differentiation of NT2/D1 cells 
NT2/D1 cells were obtained with courtesy of Dr. Wang Shu (Department of 
Biological Sciences, Institute of Bioengineering & Nanotechnology). The cells were 
routinely cultured in Delbecco’s modified Eagle’s medium (DMEM) HG including 
10% fetal bovine serum (Hyclone, USA) and 1% v/v penicillin-streptomycin (Gibco 
BRL, USA). All cells were maintained in CO2-incubators (Sanyo, Japan) at 37oC, 
10% CO2/90% room air, in 25cm2 / 75cm2 culture flasks (Nunc, USA) or Corning 
6-well plates (Corning, USA). The culture medium was changed every alternate day. 
When the cells were confluent, the medium was removed and the cells were washed 
with phosphate buffered saline (PBS) (NUMI, Singapore). The cells were then 
dislodged from the plate with Trypsin-EDTA (Sigma, USA). New medium was finally 
added to inactivate the trypsin and the cells were diluted and distributed onto new 
culture plates to grow.  
For differentiation assay with retinoic acid treatment, the induction regime and 
rationale were adopted and modified from Pleasure et al. (1993) (Figure 2.1). By 
simple, 2×106 cells were seeded in a 75 cm2 flask and treated with 1×10-5 M retinoic 
acid (a 1×10-2 M stock dissolved in dimethyl sulfoxide (DMSO) was prepared fresh 
monthly) twice a week for 4 to 5 weeks. Following RA treatment, the cells were 
replated 1:6. On the following 2 days, cells were trypsinized with 1× trypsin-EDTA 
(Gibco BRL, USA) and mechanically dislodged, that is flasks were struck ten times 
on each side and the floating cells were washed with 1× phosphate buffered saline 
twice and replated again on Poly-D-lysine (Sigma, Cat. No. P 6407, USA) pre-coated 
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6-well plates following the manufacture’s instructions (the dilution used for 
poly-D-lysine is 1: 10 w/v). Cells were seeded at a density of 0.2×106 cells per well in 
DMEM HG with 10% FBS and penicillin/streptomycin supplemented with 1uM 
cytosine arabinoside (Cat. No. C6645 Sigma, USA), 10uM fluorodeoxyuridine (Cat. 
No. F8791 Sigma, USA) and 10uM uridine (Cat. No. U3003 Sigma, USA). Cytosine 
arabinoside was continued for the first week of cell culture, and fluorodeoxyuridine 
and uridine was continued for the 4- 5 weeks of cell culture (Figure 2.1). When the 
cells reached to around 70% conferences, they were transiently transfected using 
exogenous genes (e.g. Nurr1 or Pin1) inserted into various plasmid vectors (e.g. 
pcDNA3.1, or pEGFPc1). During the transfection period (around 48 hr), the NT2/N 
cells were still induced with retinoic acid treatment until the next round of plating. 
The differentiating NT2/N cells transfected transiently with various exogenous genes 
were later lysed respectively, according to a series of time-courses (e.g. 5 d, 10 d, 16 d, 
22 d and 30 d) based on the experimental design; and the cells were stored for further 
applications and analyses.  
For neurite regeneration experiments, 1-3-week-old cultures were enzymatically 
removed with 0.025% trypsin and replated. Following re-plating, it is possible to 
freeze the fully differentiated pure cultures of neurons in 95% FBS with 5% DMSO 
and to retrieve them at a later date. 
For transiently transfected NT2N cells, we found that NT2 cells prefer 
Opti-MEM (Gibco BRL, USA) for post-transfection maintenance. NT2/N cells were 
replated at a 1:6 split ratio twice a week, and two days later after each splitting, 
NT2/N cells were transfected with the plasmids using the LipofectamineTM 2000 
transfection reagent (Invitrogen, USA) according to the recommended procedure. 
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Briefly, the cells were seeded on six-well plates at a density around 2×105 per well 
and incubated overnight. Immediately before transfection, the cells were washed three 
times in PBS. Plasmid DNA (4µg/0.5ml, 8µg/0.5ml or 20µg/0.5ml) diluted in 
Opti-MED I medium and LipofectamineTM 2000 (10µl/0.5ml) in Opti-MEM I 
medium were mixed in sterile micro-centrifuge tubes by pipetting up and down and 
incubated for 20 min at room temperature before being added into cells. After 
incubation for 4-6 hr at 37℃, the cell medium with transfection reagent was removed 
and Opti-MEM I medium containing 5% of FBS was added. After incubation for 48 
hr, the cells were harvested for western blotting analysis or fixed for 
immunocytochemical assay. In summary, the NT2/N cells were differentiated by 
retinoic acid treatment according to the following time-course-3 days, 8 days, 14 days, 
20 days, 28 days and 33 days, respectively; and subsequently, the same batches of 
differentiating NT2/N cells were transiently transfected with various genes inserted 
into expression vectors (pcDNA3.1-Myc/GFP, pEGFPc1). Meanwhile, the empty 
plasmids were also transfected into NT2/N cells as a control.  
For cryo-preservation of cells, when the cells were confluent, the medium was 
removed and the cells were washed with phosphate buffered saline (PBS). The cells 
were then enzymatically dislodged with Trypsin-EDTA and pipetted into 15ml sterile 
Falcon tube (Falcon, USA). The suspension cells were centrifuged at 1000rpm for 10 
minutes and the medium was removed. The cell pellet was washed and re-suspended 
with DMEM and applied to another 10 minutes centrifugation. Finally, the cell pellet 
was re-suspended with freezing media and aliquoted into cryo-vials (Nunc, USA). 
The cells were frozen at –80℃ for 24 hours and subsequently transferred to gas phase 
of liquid nitrogen freezer.  
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2.1.2 Cell maintenance of SH-SY5Y and MN9D cells 
MN9D cells and SH-SY5Y cells were obtained with courtesy of Dr Jun Chen 
(Department of Neurology, University of Pittsburgh) and Dr. Lim Kah Leong 
(National Neuroscience Institute, Singapore) respectively. In brief, the routine cell 
cultures of these two cell lines are the same as NT2/D1 cells. However, for cryo- 
preservation, it is optimized to freeze MN9D and SH-SY5Y cells in 50% FBS with 
40% DMEM and 10% DMSO.  
2.2 Molecular Cloning 
2.2.1 Design of Nurr1 and Pin1 sequence-specific primers 
A pair of primers, each specific for Nurr1 and Pin1 sequences respectively, was 
designed from the nucleotide sequences of human genome. Each pair comprised a 
forward (f) primer, which was identical to the sense strand (5’ → 3’), and a reverse (r) 
primer, homologous to the anti-sense strand (3’ → 5’) (Table 2.1). 
Multiple alignments of sequences coding for Nurr1 and Pin1, respectively, were 
first made using DNAMAN program. Short sequences were then selected from 
regions of high homology, according to various criteria, which included  
(a) a length of 15 to 30 bp; 
(b) a random base distribution with a G+C content of at least 50% 
(c) a melting temperature Tm of 55 ℃ to 80 ℃ 
(d) an absence of any form of significant secondary structures; and 
(e) an absence of any sequence complementary at the 3’ ends of the primer    
pairs. 
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The specificity of the sequences of the potential primers was subsequently 
verified by BLAST. 
 
2.2.2 Generation of SH-SY5Y cells cDNA molecules 
2.2.2.1 Isolation of total RNA from SH-SY5Y cells  
2.2.2.1.1 Total RNA extraction with reagent 
Total RNA of SH-SY5Y cells were extracted via RNeasy mini kit (QIAGEN, 
Germany). 
When the number of SH-SY5Y cells reached around 1×107, the cell-culture 
medium was completely aspirated and washed by PBS twice. After the PBS was 
removed from cell culture dishes, 0.10% trypsin in PBS was added to trypsinize the 
cells. After cells detached from the culture dishes, DMEM was added to inactivate 
and neutralize the trypsin. The cells was transferred to an RNase-free polypropylene 
centrifuge tube and centrifuged at 300×g for 5 min. The supernatant was completely 
aspirated and pelleted cells were loosened thoroughly by flicking the tube. The 
appropriate volume of Buffer RLT was added according to manufacture’s instruction. 
The mixture was gently vortexed or pipetted, and the lysate was passed through a 
20-gauge needle (0.9 mm diameter) fitted to an RNase-free syringe at least 5 times. 
After homogenization, 1 volume of 70% ethanol was added to the lysate and mixed 
well by pipetting. Up to 700µl of the sample was applied to an RNeasy mini column 
placed in a 2ml collection tube, followed by centrifugation for 15 s at 12,000rpm. 
700µl Buffer RW1 and 500µl Buffer RPE and another 500µl Buffer RPE were added 
onto the RNeasy column subsequently for every centrifugation at 12,000rpm for 1 
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min per time. The RNeasy column was then transferred to a new sterile 
microcentrifuge tube and eluted with 30µl RNase-free water via centrifugation for 
1min at maximum speed. The total RNA can be stored at –80℃ freezer for later use.  
 
2.2.2.1.2 Quantification of nucleic acids 
The concentration of each nucleic acid sample was determined by 
spectrophotometer. A 50- or 100-fold dilution of the sample was first prepared for a 
1µl aliquot of each sample, from which the optical density at 260nm (OD260) was 
measured using a quartz micro-cuvette. The amount of nucleic acids present was then 
determined using the following equation: 
  Concentration of sample= OD×d×a 
where d is the dilution factor, and a represents the amount of nucleic acids 
equivalent to 1 OD unit. The typical values of a are 50µg/ml for DNA and 40µg/ml 
for RNA.  
The purity of each sample could also be assessed by determining its optical 
density value at 280nm (OD280) and thereafter was determined by OD260/OD280 ratio. 
Typically, RNA sample with a ratio of 1.8-2.0 was considered relatively pure, while 
for pure DNA samples, the ratio was expected to be more than 1.85. 
 
2.2.2.2 Polymerase chain reaction (PCR) of SH-SY5Y cell total RNA  
2.2.2.2.1 Standard PCR 
PCR is a powerful too to amplify DNA fragments million of times by a 
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thermostable DNA polymerase and a pair of primers. It was extensively used for 
various purposes such as rapid amplification of cDNA ends (RACE) and colony 
screening. 
PCR was performed in a 20 or 50µl reaction using the PTC-100TM programmable 
thermal controller (MJ Research, USA). Typical components and program used of 
PCR reaction are referred to Table 2.2. and Table 2.3. 
 
2.2.2.2.2 RT-PCR (Reverse transcription PCR) of SH-SY5Y cell total RNA 
Complementary DNA (cDNAs) strands were synthesized from SH-SY5Y cell 
total RNA using the Access RT-PCR System Kit (Promega, USA). A sample mixture 
of 20 or 50µl reaction was performed using PTC-100TM programmable thermal 
controller. Typical components and program used of RT-PCR reaction are referred to 
Table 2.4 and 2.5. 
 
2.2.3 Gel electrophoresis of DNA 
Products of the PCR reaction were analyzed via horizontal gel electrophoresis, 
according to manufacture’s instruction. 
The DNA samples were each mixed with 1× loading buffer [6×: 0.25% (w/v) 
bromophenol blue (Sigma, USA), 0.25% (w/v) xylene cyanol ff (Sigma, USA), 30% 
(v/v) glycerol (Sigma, USA)]. They were then loaded into the wells of an 1.0% 
agarose (Promega, USA) gel in 1×TAE buffer [0.04M Tris-acetate, 0.01M EDTA, 
pH8.0 ]. A DNA ladder of λDNA-EcoRI/HindIII digest (Promega, USA) was 
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Electrophoresis was carried out at a constant voltage of 100V in 1×TAE buffer, 
until the bromophenol blue front had migrated two-third of the length of the gel. The 
DNA samples were visualized in UV light at 254nm and documented onto black and 
white Polaroid Type 667 film, using a Photoman camera (Hoefer, USA). 
 
2.2.4 Purification of DNA  
The agarose-DNA complex was incubated at 50℃ for 10min in 3 volumes of 
Buffer QC, before it was mixed with 1 volume of isopropanol (Merck, Germany). The 
pH of the sample was determined and adjusted, if necessary, with 3 M sodium acetate 
(pH 5.0) to less than pH 7.5 to ensure the subsequent absorption of the DNA to the 
QIAquick TM membrane. 
The sample was loaded into a QIAquick TM spin column placed within a 2ml 
collection tube at the maximum volume of 800µl per loading. It was then centrifuged 
for 1 min in a tabletop centrifuge and the resultant flow-through in the collection tube 
was discarded. For samples with large volumes, multiple loadings into the same spin 
column were carried out. After all the DNA from the sample has been absorbed onto 
the membrane, 500µl of Buffer QC was added to the spin column and after 
centrifugation for 1 min 750µl of Buffer PE was added to wash the column by 
centrifugation for 1 min. Residual ethanol present in the column, which would 
interfere with elution, was removed by an additional spin.  
The DNA was subsequently eluted by adding 50µl of PCR water directly onto the 
QIAquick TM membrane. After standing the column for 1 min, the DNA sample was 
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collected into a 1.5ml sterile eppendorf tube via centrifugation and was stored at 
–20℃ freezer until use.  
 
2.2.5 Production of recombinant DNA molecules 
2.2.5.1 Ligation of cDNA products to pGEM T-easyTM cloning vector 
The cDNA products were subsequently sub-cloned into the vector by using 
pGEM T-easy vector system I kit (Promega, USA). DNA ligation reaction was carried 
out typically in 10µl of volume, containing 5µl of 2×ligation buffer, 0.5µl of vector 
DNA, 3µl of insert DNA generated by Taq DNA polymerase and 1µl of T4 DNA 
ligase and topped up with PCR water to 10µl final volume. The ligation mixture was 
incubated at 4℃ for above 16 hrs before transformation.  
Alternatively, thermostable DNA polymerases with proofreading activity, such as 
Pfu DNA polymerase and Tfl DNA polymerase generate blunt-ended fragments 
during PCR amplification. Nevertheless, these PCR fragments can be modified using 
the A-tailing procedure before ligation into the pGEM-T easy vectors. Using this 
method, only one insert will be ligated into the vector as opposed to multiple 
insertions that can occur with blunt-ended cloning. In addition, with T-vector cloning 
there is on need to de-phosphorylate the vector. In brief, 1-7µl of purified PCR 
fragment was mixed with 1µl Taq DNA polymerase 10×reaction buffer with MgCl2, 
5 units of Taq DNA polymerase and dATP was added to a final concentration of 0.2 
mM. The reaction mixture was topped with deionized water to a final reaction volume 
of 10µl and then incubated at 70℃ for 15-30 min. The modified PCR fragment can 
then be ligated directly into pGEM-T easy vector using standard protocol as above. 
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2.2.5.2 Transformation of super-competent host cells 
2.2.5.2.1 Preparation of competent cells 
Successful cloning relies on high efficiency of transformation. Normally above 
107 transformed colonies per µg of supercoiled plasmid is good enough for most 
cloning applications. 
For the preparation of competent bacteria cells, 20ml of LB broth was incubated 
with a single fresh colony of Escherichia coli (E.coli) strain Top10 (Invitrogen, USA) 
at 37℃ with 250rpm shaking overnight. In the following morning, 1ml of the culture 
was spiked into 200ml of fresh LB medium and shaken at 250rpm at 37℃ until OD600 
reached around 0.5. The culture was chilled on ice for 15 min and transferred to 
pre-chilled sterile 50ml Falcon tubes. Cells were pelleted by centrifugation at 
4,100rpm at 4℃ for 10 min. The cell pellets were drained by standing the tubes 
up-side-down on a pad of paper towels for 1 min and re-suspended in ice-cold 
MgCl2-CaCl2 solution (80 mM MgCl2, 20 mM CaCl2) with 1/3 volume of the original 
bacteria culture. After incubation on ice for 10 min, the cells were recovered by 
centrifugation at 4,100rpm for 10 min at 4℃ and re-suspended in 2ml of ice-cold 
0.1M CaCl2 for each 50 ml of original culture. At this point, either use the cells 
directly for transformation or dispense into aliquots by adding 4ml of freezing 
medium [50% glycerol (w/v), 50% (v/v) 0.1M CaCl2] and thoroughly pipetted. After 
20 min incubation on ice, the competent cells were stored at –80℃ freezer for several 
months. 
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Normally 5µl of ligation reaction was mixed with 100µl of E. coli Top10 
competent cells. The mixture was incubated on ice for 20 min and then heated at 37℃ 
for 5 min. The tube was cooled immediately on ice for 2 min and mixed with 400µl of 
LB medium without antibiotics. After being incubated at 37℃ for 1 hr with shaking at 
250rpm, the transformation reaction mixture were centrifuged at 3000rpm for 1 min 
and then 1/10 of the mixture was spread by inoculating loops onto LB plates later 
colony selection.  
The LB plates were supplements with X-gal and IPTG in the presence of 20µg 
/ml ampicillin. After an overnight incubation at 37℃, colonies of transformed cells 
were selected according to their antibiotic resistance and lac- phenotype. White 
colonies were chosen, from each of which cells were picked up via a sterile toothpick 
and were streaked onto individual sectors of a LB plate supplemented with 20µg/ml 
ampicillin with incubation overnight at 37℃.  
 
2.2.6 Selection of recombinant colonies 
2.2.6.1 Screening of selected recombinant colonies 
Inserts in the selected colonies were detected via direct PCR screening. A T7 
promoter primer (5’-GTAATACGACTCACTATAGGGC-3’) and a SP6 promoter 
primer (5’-) which bind to complementary sites flanking the multiple cloning sites 
(MCS) of the pGEM-T easy vector were used. A reaction mixture comprising 0.5uM 
of each pair of primers, 0.25mM dNTPs, 0.03 U/µl of Taq DNA polymerase was 
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prepared for each colony to be screened. After introducing the cells via a sterile 
toothpick, PCR was carried out as previously described, at an annealing temperature 
of 55℃. Colonies which contained the inserts were identified by agarose gel 
electrophoresis and were prepared for sequencing.  
 
2.2.6.2 Culture and harvesting of bacterial cells 
A small scale liquid culture of each bacterial colony was made in 3ml Luria 
Bertani (LB) broth (OXOID, UK) supplemented with 20µg/ml ampicillin. Cells from 
the colony were introduced were introduced into the medium via a sterile toothpick or 
pipette tip under aseptic conditions to prevent contamination. The cultures were then 
incubated overnight at 37℃ with shaking at approximately 250rpm. Cells from each 
culture were harvested by dispensing 1.5ml of the culture into a sterile 1.5ml 
micro-centrifuge tube, and centrifuged at 8000rpm for 1 min. After discarding the 
supernatant, this procedure was repeated for another 1.5ml of culture.  
 
2.2.6.3 Isolation and purification of plasmid DNA 
Small-scale preparation of plasmid DNA was carried out using Qiagen Mini-prep 
Kit (Qiagen, Germany). The protocol involved alkaline lyses followed by binding of 
plasmid DNA to a silica-based resin. DNA was eluded in low salt buffer or water. 
Normally, around 10 µg of high copy number plasmid DNA can be isolated from 3ml 
of overnight bacteria culture in LB medium.  
  Firstly, the bacteria in LB liquid medium with appropriate antibiotics were 
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harvested by centrifugation at 8,000rpm for 1 minute using the 5417C centrifuge 
(Eppendorf, Germany). Then the bacterial pellet was re-suspended in 250µl of Cell 
Re-suspension Solution (100 mg/ml RNAse A; 10mM EDTA; 25 mM Tris-HCl, 
pH7.5). 250µl of Cell Lyses Solution (0.2M NaOH; 1% SDS) was added to the 
bacterial suspension and mixed by gently inverting the tubes for 4-6 times. The 
mixture was neutralized by adding 350µl of Neutralization Bugger (1.32 M KOAc, 
pH4.8). After being centrifuged in a micro-centrifuge tube at 14,000rpm for 10 
minutes, the supernatant was transferred into a Purification Resin with a fresh 2ml 
collection tube. The resin/DNA mix was washed with Column Wash Buffer using 
centrifugation. The resin was drained by spinning down together with the collection 
tube at 14,000rpm at another 1 minute. The mini-column was then transferred to a 
new micro-centrifuge tube and eluted with 30µl of PCR water. After 1 min incubation 
at room temperature, plasmid DNA was eluted from the column by centrifugation at 
14,000rpm for 1 minute. 
 
2.2.7 Enzymatic manipulation of plasmid DNA 
2.2.7.1 Restriction endonuclease digestion of DNA 
Restriction enzyme digestion was employed to screen recombinant clones and 
release specific DNA fragments.  
All the restriction enzymes used in the study were purchased from New England 
Biolabs or Promega (USA). All digestions were performed at 37℃ according to the 
characteristics of different restriction enzymes and manufacture’s instructions. 
Normally 3 units of enzymes were used to digest 1µg of plasmid DNA (Table 2.6). 
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2.2.8 Double strand DNA sequencing   
2.2.8.1 Sequencing PCR reaction 
Sequenced products of the cDNA molecules were generated by the Taq Dyedoxy 
TM Terminator Cycle Sequencing Kit (Applied Biosystems, USA). The composition of 
a 5µl sequencing reaction mixture is give in table 2.3 and apart from the template, the 
other components were added as a terminator premix provided by the reaction kit. The 
cycle sequencing reaction was performed at the temperature profile of 
  denaturing at 95℃ for 30s 
  annealing at 50℃ for 10s, and 
  extension at 60℃ for 4min. 
for 20 cycles, after which the samples were incubated at 4℃.  
 
2.2.8.2 Precipitation of DNA 
After sequencing PCR reaction, each of the 5µl reaction was transferred to a 
1.5ml micro-centrifuge tube containing 80µl of the precipitation solution [3.0µl of 
3M sodium acetate, pH4.6, 14.5µl of ddH2O, 62.5µl of 95% ethanol] and mixed well 
by pipetting up and down. The entire contents of each reaction was kept at room 
temperature for 20min and then centrifuged at 14,000rpm for 20min. The supernatant 
was carefully aspirated and discarded; the pellet was rinsed with 500µl of 70% 
ethanol and spun down at 14,000rpm for 5 min. After rinsing and spinning down 
twice, the pellet was dried at 37℃ for half an hour and then applied to sequencing 
directly or stored at –20℃ freezer for later use (no more than two weeks).  
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2.2.8.3 Automated sequencing 
Automated sequencing reactions were carried out using the ABI PRISMTM 
BigDyeTM Terminator Cycle Sequencing Ready Reaction Kit (AB Applied Biosystem, 
USA). The DNA pellet was dissolved in 12µl of HiDye (Applied Biosystems, USA) 
and heated to 95℃ for 5 min. Sample plate was then chilled on ice for 2 min and 
loaded into the ABI3100 sequencer system. The data was collected and analyzed by 
the according software. 
 
2.2.9 Gene transfection 
Vectors generating the human Pin1 cDNA were constructed using the standard 
recombinant DNA techniques as described above. The eukaryotic expression vector 
pcDNA3.1 tagged with Myc or GFP and vector pEGFPc1 were obtained from Dr. 
Arenas (Karolinska Institute, Sweden). Pin1 cDNA flanked with XbaI and XholI in 
5’-end and 3’-end respectively was sub-cloned into the pcDNA3.1 vectors. Vector 
pCMX, which is generating the human Nurr1 cDNA, was donated by Dr. Thomas 
Perlmann (Karolinska Institute, Sweden). Nurr1 cDNA flanked with HindIII and 
BamHI in 5’-end and 3’-end was sub-cloned into the pEGFPc1 vector. Restriction 
enzyme analysis and nucleic acid sequencing ascertained the orientation of the Pin1 
and Nurr1 inserts. 
NT2/N cells were replated at a 1:6 split ratio twice a week, and two days later 
after each splitting, NT2/N cells were transfected with the plasmids using the 
LipofectamineTM 2000 transfection reagent (Invitrogen, USA) according to the 
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recommended procedure. Briefly, the cells were seeded on six-well plates at a density 
around 2×105 per well and incubated overnight. Immediately before transfection, the 
cells were washed three times in PBS. Plasmid DNA (4µg/0.5ml) diluted in 
Opti-MED I medium and LipofectamineTM 2000 (10µl/0.5ml) in Opti-MEM I 
medium were mixed in sterile micro-centrifuge tubes by pipetting up and down and 
incubated for 20 min at room temperature before being added into cells. After 
incubation for 4-6 hr at 37℃, the cell medium with transfection reagent was removed 
and Opti-MEM I medium containing 5% of FBS was added. After incubation for 48 
hr, the cells were harvested for western blotting analysis or fixed for 
immunocytochemical assay.  
 
2.3 Protein applications 
2.3.1 Protein Extraction 
Prior to lyses, both NT2/N cells and SH-SY5Y cells subjected to the various 
experimental conditions were washed with PBS to remove the medium. A volume of 
60-200µl of cell lyses buffer [100mM HEPES pH 7.5, 5mM MgCl2, 150mM NaCl, 
1mM EDTA, 1% Triton + 1% protease inhibitor cocktail (AEBSF-Hydrochloride, 
Aprotinin, E-64-Protease Inhibitor, EDTA-Disodium, Leupeptin-Hemisulfate) + 1% 
sodium orthovalidate + 2% sodium fluoride](Calbiochem, USA) was added to lyse 
the cells according to the various areas of cell culture. The cell lysate was stored at 
–80oC overnight, and next day was centrifuged at 13,000rpm for 10 min to pellet the 
DNA and the supernatant was stored at –20oC for later use.  
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2.3.2 Bradford Protein Assay 
The protein concentrations of the cell lysate were determined using the standard 
Bradford protein assay (Biorad, USA). Standard solutions were prepared using bovine 
serum albumin (BSA) diluted to 5mg/ml, 10mg/ml, 15mg/ml, 20mg/ml and 25mg/ml, 
respectively, to obtain the standard curve for determination of the protein 
concentration of the unknown samples. The Bradford assay solution at 25µl was 
added to 100µl of each of the diluted protein samples as well as the standards. The 
mixtures were incubated at room temperature for 5 minutes before the optical density 
was determined at 595nm. The protein concentrations of the samples were determined 
by using its optical density value to plot against the standard curve. 
 
2.3.3 Protein Separation 
The protein samples were normalized to a standard concentration of either 
20mg/ml or 40mg/ml and the required amount were mixed with the 4x -loading buffer 
(100mM DTT, 160mM Tris pH 6.8, 4% SDS, 20% glycerol and 0.1% bromophenol 
blue). The mixtures were boiled at 95oC for 5 min to denature and linearize the 
proteins. The pre-calculated amounts of each sample were then loaded into the wells 
of a 12% sodium dodecyl sulphate-polyacrylamide gel (SDS-PAGE) and subjected to 
a constant voltage of 100V for 1.5h in 1x running buffer (192mM glycine, 25mM Tris 
and 0.1% SDS). 
SDS-PAGE gels were cast using the Bio-Rad protein mini-gel apparatus. 10ml of 
12% w/v resolving gel and 4 ml of 4% stacking gel were prepared as in Table 2.7 
APS (ammonium persulphate) and TEMED (N, N, N, N-tetramethylethylene- 
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diamine) were added after the gel mixture was degassed. The resolving gel was 
poured into the space between the two plates to a height such that it was about 5 mm 
from the bottom of the comb. The gel was layered with isopropanol to allow the 
polymerization of polyacrylamide. After the resolving gel was set, the isopropanol 
was decanted and the excess was absorbed by a slide of filter paper. The stacking gel 
was poured above the resolving gel and the comb was inserted. The gel was allowed 
to polymerize for 30 min.  
After electrophoresis, the gel was stained in 50ml of staining solution [10% 
acetic acid, 45% isopropanol, 0.1% Coomassie brilliant blue] for 30 min. The gel was 
then destained in destaining solution [10% (v/v) methanol; 10% (v/v) acetic acid] for 
several hours to overnight by gently shaking.  
 
2.3.4 Western blot analysis 
The protein samples were separated in 12% SDS-PAGE gel as described above. 
The proteins were then transferred to nitrocellulose membranes (Bio-Rad, USA) using 
an electro-blotting apparatus (Bio-Rad, USA) at a constant voltage of 85V for 1.5h in 
the transferring buffer [7.202g of glycine, 12 ml of 1M Tris-HCl (pH7.4), 20% 
methanol]. The blots were blocked overnight in a blocking buffer [TBS (27ml of 5M 
NaCl, 12ml of 1M Tris-HCl pH 7.4) + 0.1% Tween 20 + 5% BSA or non-fat dry 
milk]. The blots were then incubated with a primary antibody in 2% BSA or non-fat 
dry milk at 4℃ overnight with gently shaking. All the blots were washed five times at 
5 minutes each with TBST [TBS + 0.1% Tween-20] and then incubated with the 
secondary antibodies [anti-rabbit-HRP (1:1000) or anti-mouse-HRP (1:1000)] 
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against the primary antibodies for 1 hr at room temperature. The free antibodies were 
removed by five washes with TBST for 5 min each at room temperature. The blots 
were finally developed with the enhanced chemiluminescent (ECL) kit (Pierce, USA) 
and the signals were detected on Pierce films (Pierce, USA). The different blotting 
conditions and antibody applications are indicated on Table 2.7 
 
2.3.5 Immunocytochemical assay 
NT2/N cells were cultured on 6-well plates coated with poly-D-lysine (Sigma, 
USA). The cells were washed 3 times with PBS and then fixed with 4% 
paraformaldehyde (Sigma, USA) dissolved in PBS and incubated at 4℃ for up to 2 hr.  
The fixed cells were washed 3 times with PBS for 5 min each at room temperature by 
gently shaking and then blocked with blocking buffer [5% goat serum, 2% BSA, 
0.4% TritonX-100 in PBS] for 20 min with gently shaking. The cells were washed 
with washing buffer [0.4% TritonX-100 in PBS] 3 times before incubating with 
primary antibody dissolved with probing buffer [2% goat serum, 1% BSA in PBS] at 
room temperature for 2 hr with gently shaking. The cells were then washed thrice 
with PBS and then incubated in dark with secondary antibody conjugated with 
fluorescein (1:100 Texas Red-conjugated anti-rabbit or –mouse, Santa Cruz, USA) for 
2 hr at room temperature. The cells were again washed thrice with PBS followed by 
photography using the Zeiss Axiovert 200M (Zeiss, Germany). The images were 
processed and edited using the AxioVision 4.0 image browser program (Zeiss, 
Germany).  
 
                                                                                                     43




SH-SY5Y cells were cultured to 80% confluence after gene transfection on 10cm 
culture plate (Cornings, USA). The medium was discarded and the cells were washed 
with pre-chilled PBS 3 times. The cells were then lysed using with cell lyses buffer 
described as in 2.3.1.  
 
2.3.6.1 Prepare antibody-conjugated beads 
10µg of the specific antibody was mixed with 30µl of 50% protein G-Sepharose 
bead slurry together with 0.5ml of ice-cold PBS and then added with 0.01% Triton-X 
dissolved in PBS. The mixture was suspended thoroughly and incubated end over end 
overnight at 4℃ in a tube rotator. After tumble incubation, the mixture was 
centrifuged for 2 sec at 16,000g at 4℃ and then the supernatant was aspirated and 
kept at –20℃ for later analysis. The pellet beads were added with 1ml of 
non-denaturing cell lyses buffer as described in 2.3.1 and re-suspended by inverting 
the tube 4 times. After centrifugation and washing for 4-5 times, the 
antibody-conjugated beads can be stored up to 6 hours at 4℃ before use. 
 
2.3.6.2 Pre-clear cell lysate 
In a micro-centrifuge tube, 1ml of cell lysate and 30µl of 50% protein 
G-Sepharose bead slurry was combined and tumbled end over end at 4℃ in a tube 
rotator up to 30 min before centrifugation 5 min at 16,000g at 4℃. To avoid protease 
activity, 1% of protease inhibitor (Calbiochem, USA) was added into the cell lysate. 
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2.3.6.3 Protein pull-down assay  
The specific antibody bound to protein G-Sepharose bead was mixed with 10µl 
of 10% BSA and the entire volume of pre-cleared cell lysate. The mixture was 
incubated for 1 to 2 hr at 4℃ while mixing end over end in a tube rotator and then 
centrifuged for 5 sec at 16,000g at 4℃. The supernatant was aspirated and can be kept 
up to 8 hr at 4℃ or up to 1 month at –80℃ for later analysis. The bead with bound 
proteins was washed with 1ml of ice-cold wash buffer [0.01% TritonX-100 in PBS] 
and re-suspended by inverting the tube 4 times before centrifugation for 5 sec at 
16,000g at 4℃. After repeat washing and spinning down 4 times, the bead was 
washed one more time with 1ml of ice-cold PBS and the 20 to 40µl of supernatant 
was on top of the bead. The immune-complex can be either processed immediately or 
frozen at –20℃ for later analysis.  
 
2.3.6.4 Co-immunoprecipitation 
For immunoblotting analysis, the proteins bound to the specific antibody with 
protein A/G-Sepharose beads as described above were resolved on SDS-PAGE and 
blotted; protein pieces were detected with the reverse antibody to which the specific 
protein was expected to be pulled down by the above immunoprecipitation step. The 
immuno-detection procedures were as described as in 2.3.4. 
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2.4 Cell Cycle Analysis (FACS) 
2.4.1 Harvesting of cell for flow cytometry 
NT2/N cells were differentiated at various stages for cell cycle analysis. The cell 
culture medium was discarded and the cells were washed with PBS thrice. The cells 
were trypsinized and harvested with DMEM by pipetting into 15ml Falcon tubes, 
centrifugation at 2,000rpm for 10 min at 4℃. The supernatant was discarded and the 
pellet was washed with 5ml of PBS. The cell pellet was re-suspended with PBS and 
spun down for another 10 min at 4℃. The supernatant was decanted and the pellet 
was fixed with 0.5% paraformaldehyde for 5 min on ice to prevent GFP leakage. The 
test tubes were centrifuged again and the paraformaldehyde was discarded. The cell 
pellets were re-suspended with 0.5ml of PBS and added drop by drop with 4.5 of 
ice-cold (pre-chilled at –20℃) 70% ethanol. After which, the cells in test tubes can 
be stored up to 1 month at –20℃ until proceeding to flow cytometry. 
 
2.4.2 Flow cytometry analysis 
The fixed cells were centrifuged at 5,000rpm for 10 min at 4℃ and the ethanol 
was discarded. The test tubes were air-dried by inverting them on a pad of c-fold 
towel. The PI staining of cells was performed by adding PI staining solution 
containing 500µl of sample buffer [stock solution: 1g glucose dissolved in 1L of 
PBS, filtered], 10µl of 1000 U/ml RNase A and 5µl of 1mg/ml propidium iodide 
dissolved in PBS, and the samples were incubated in dark at room temperature for 30 
                                                                                                     46
               
 
Chapter II 
min. The cell samples were filtered through the 41um nylon filter and then subjected 
to flow cytometry.  
Flow cytometric analysis was carried out on 10,000-gated 
EGFP/GFP-expressing cells using a FACSCalibur flow cytometer and the data were 
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2 million NT2 cells per T25 flask 
Replate #1-cells are replated at lower density (1:6) 
10µM RA 2Χ/week for 4 weeks 
Replate #2- cells mechanically dislodged and 
replated 
>95% pure NT2-N cultures which are fully viable 
for up to ten weeks
Cryopreserved and stored at-1800C prior to further 
use 
Cells treated with mitotic inhibitors 
Replate #3-cells removed enzymatically and replated on various substrates to 
study neurite regeneration-the yield at this step is>99% pure NT2-N cells 
Figure 2.1 Schematic demonstration of the method devised for generation of 
pure cultures of NT2/N cells from retinoic acid-treated NT2/D1 cells.  
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Plasmid Name Sequence Annealing 
Tm (℃) 
Pin1 (cds) pGEM-T (easy) 5’ atggcggacgaggagaagctgccg 3’ 71.4 
Pin1 (cds) pGEM-T (easy) 3’ tcactcagtgcggaggatgatgtg  5’ 66.3 
Pin1-XbalI pcDNA3.1-GFP/Myc 5’ tctagaatggcggacgaggagaagctg 3’ 69.2 
Pin1-XholI pcDNA3.1-GFP/Myc 3’ctcgagctcagtgcggaggatgatgtg 5’ 70.7 
NOT-HindIII pEGFPc1 5’gtttcacaagcttcgatgccttgtgttcaggcgca 
3’ 
71.7 
NOT-BamHI pEGFPc1 3’cttgggagggatccttagaaaggtaaagtgtc5’ 68.5 
 
Table 2.1 Sequences and properties of the primers Pin1 and Nurr1.  
The plasmid name, length and melting temperature (Tm) are indicated.   
 
Reaction component Final concentration 
Template 
1 µl of a 100-fold dilution of plasmid 
sample 
PCR Buffer 
1×[50mM KCl, 10mM Tris-HCl (pH9.0), 
0.1%(v/v) Triton X-100 
MgCl2 1.5mM 
dNTPs 0.2mM 
Primers 1.0µM each 
Taq DNA polymerase (Promega, USA) 0.05 U/µl 
 
Table 2.2 Composition of a typical PCR reaction  
 
Primers Stage Temperature Duration 
Denaturing 95 ℃ 30 sec 
Annealing 62 ℃ 30 sec 
Pin1(forward) 
Pin1 (reverse) 
Extension 72 ℃  1.5 min 
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Reaction component Final concentration 
Template 
1 µl of a 100-fold dilution of plasmid 
sample 
PCR Buffer 
1×[50mM KCl, 10mM Tris-HCl (pH9.0), 
0.1%(v/v) Triton X-100 
MgCl2 1.5mM 
dNTPs 0.2mM 
Primers 1.0µM each 
Pfu 0.01 U/µl 
Reaction component Final concentration 
Template 
1 µl of a 100-fold dilution of plasmid 
sample 
PCR Buffer 
1×[50mM KCl, 10mM Tris-HCl (pH9.0), 
0.1%(v/v) Triton X-100 
MgSO4 1.5mM 
dNTPs 0.2mM 
Primers 1.0µM each 
AMV (polymerase) 0.01 U/µl 
Tfl (reverse transcriptase) 0.01U/µl 
Primers Stage Temperature Duration 
Denaturing 95 ℃ 30 sec 
Annealing 64 ℃ 30 sec  
Nurr1(forward) 
Nurr1(reverse) 
Extension 72 ℃  2 min 
Denaturing 95 ℃ 30 sec 
Annealing 58 ℃ 30 sec 
Pin1 (forward) 
Pin1 (reverse) 
Extension 72 ℃ 1.5 min 
 
Table 2.4 Temperature profile of PCR involving gene-specific primers 
 
 
Table 2.5 Composition of one-step RT-PCR reaction  
 
Table 2.6 Composition of PCR reaction involving Nurr1-specific primers 
 
               
 

















Figure 2.2 Plasmid map of pEGFPC1 cloning vector.  
(a) The regions defining the multiple cloning sites (MCS), CMV promoter region, kanamycin/neomycin resistance gene and the plasmid 
origin of replication (pUC) are indicated. In addition, the various restriction sites located within the MCS as well as elsewhere in the 
plasmid are given. (b) The positions of various restriction sites within MCS are depicted. 
(The figure is reproduced from the webpage of BD Biosciences Clontech.)  
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 Supply source Dilution factor Blocking condition Incubation condition 
anti-Nurr1 (sc-990) Santa Cruz Biotech. 
(USA) 
1:1000 in non-fat milk 5% non-fat milk, 45 min, 
at RT 




Santa Cruz Biotech. 
(USA) 
Cell Signaling (USA) 
1:800, 2% non-fat milk 
 
1:2000, 5% BSA  
5% non-fat milk, 20 min, 
at RT 
5% non-fat milk, 30 min 
1 hour, at RT 
 
overnight, at 4℃ 
anti-DAT (MAB369) Chemicon (USA) 1:500, 2% non-fat milk 5% non-fat milk, 45 min overnight, at 4℃ 
anti-TH (MAB318) Chemicon (USA) 1:1000, 2% non-fat milk 5% non-fat milk, 45 min overnight, at 4℃ 
anti-phospho-TH (#2791) Cell Signaling (USA) 1:1000, 5% BSA 5% non-fat milk, 30 min overnight, at 4℃ 
anti-D2DR (sc-5303) Santa Cruz Biotech. 
(USA) 
1:500, 2% non-fat milk 5% non-fat milk, 30 min overnight, at 4℃ 
anti-Cyclin D1 (#2926) Cell Signaling (USA) 1:2000, 2% non-fat milk 5% non-fat milk, 30 min overnight, at 4℃ 
anti-Cyclin B1 (sc-595) Santa Cruz Biotech. 
(USA) 
1:500, 2% non-fat milk 5% non-fat milk, 30 min overnight, at 4℃ 
anti-Cdk6 (#3136) Cell Signaling (USA) 1:1000, 2% non-fat milk 5% non-fat milk, 30 min overnight, at 4℃ 
anti-D2DR Santa Cruz Biotech. 
(USA) 
1:500, 2% non-fat milk 5% non-fat milk, 30 min overnight, at 4℃ 
anti-Actin Santa Cruz Biotech. 
(USA) 
1:1000, 2% BSA 5% BSA, 2 hours overnight, at 4℃ 
 
Table 2.7 Summary of antibody application for western blotting  
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    Cloning of human Nurr1 
and Pin1 genes from 
neuroblastoma cells 
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3.1 Introduction 
Nurr1 is one of more than 20 orphan members of the nuclear receptor family. 
Like other nuclear receptors, Nurr1 binds to specific DNA-binding sites in the vicinity 
of regulated genes and can recognize DNA as a monomer, homodimer, or 
heterodimers with the heterodimerization partner (Law et al., 1992). The importance 
of Nurr1 in developing and mature DA neurons has focused interest on Nurr1 as a 
potential drug target, and major effects have been invested in finding ligands that can 
bind and activate this receptor. Thus, with this consideration in mind, the present 
study was designed to identify Nurr1 cooperators/ligands and meanwhile to explore 
the upstream function of Nurr1 involved in DA neuron development. The relevant 
sub-cloning work was carried out to set up the mammalian expression system of 
Nurr1 for further studies in Chapter 4. 
 
Pin1, as introduced in Chapter 1, has been involved in the pathogenetic studies of 
Alzheimer’s disease so far. However, due to the correlations and similarities among 
difference types of neurodegeneration studies, it is interesting for the author to 
explore the possible involvement of Pin1 in Parkinson’s disease. Hereby, firstly, 
RT-PCR was successfully carried out using total RNA extracted from SH-SY5Y 
neuroblastoma cell line to obtain the cDNA of Pin1. Then, the subsequent PCR work 
was to establish the mammalian expression system of Pin1 for further studies in 
Chapter 4. 
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Summarily, the present chapter describes the cloning and sub-cloning of Pin1 and 
Nurr1, respectively. The various plasmid constructs of these two genes were obtained 
using primers that were designed from Nurr1- and Pin1- sequences of human. Their 
identities as human sequences are discussed with respect to their similarities to the 
sequences available in GENEBANK.  
 
3.2 Results and discussions 
3.2.1 Cloning of human Pin1 gene 
3.2.1.1 Isolation of Pin1 gene 
In order to isolate human cDNAs for cloning of Pin1, a pair of primers (Table 3.1) 
were designed based on the 5’-end and 3’-end coding sequences of Pin1 from known 
full length sequences accessed through NCBI databases (GENBANK Accession 
Number: NM_006221). Human total RNA isolated from SH-SY5Y, which is a human 
neuroblastoma cell line, was used as a template for reverse-transcription of human 
mRNAs to cDNAs. After one-step RT-PCR reverse-transcription and amplification, 
the predicted 495bp fragment was generated and purified (Figure 3.1). The PCR 
product of Pin1 was cloned into pGEM-T easy vector and 12 randomly selected 
clones were initially sequenced and the correct sequences of prospective inserts were 
identified (Figure 3.2) and subsequently digested double enzymatically to detect the 
Pin1-like insert from pGEM-T easy vectors (Figure 3.3). Thus, another pair of 
primers, with XbalI and XholI restriction endonuclease sites flanked 5’ and 3’ ends of 
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coding sequence of Pin1 gene respectively, was designed for sub-cloning Pin1 gene 
into a mammalian expression vector, pcDNA3.1 with GFP or Myc tag flanked 3’ end 
of multiple cloning sites (Table 3.1) 
 
3.2.1.2 Sequencing and multiple alignment of Pin1 
In order to determine if the 498bp product is a human Pin1 cDNA sequence and 
to enable subsequent protein translation in vivo, it was sub-cloned into the pcDNA3.1 
expression vector and transformed into TOP 10 (Invitrogen, USA) competent cells. 
Selection of recombinant colonies on the basis of antibiotic resistance and subsequent 
direct colony screening by PCR with T7 and SP6 promoter primers identified 7 
colonies (Figure 3.4). The presence of the cDNA inserts was confirmed using XbalI 
and XholI double enzymatic digestion. Two of them were verified to have a 492bp 
Pin1-like insert released from pcDNA3.1-GFP/Myc vectors and then subjected to 
sequencing analysis. 
Comparison of the nucleotide sequence of Pin1 with those available in 
GENBANK via BLAST showed that it had 100 percent match scores with the human 
sequences of Pin1 in database. The restriction endonuclease sites-XbalI and XholI 
flanked 5’ end and 3’ end of the coding sequence of Pin1 gene was confirmed using 
alignment of engineered coding sequence of Pin1 with the full-length human Pin1 
cDNA sequence (Figure 3.6a). Therefore, finally, a fusion protein of GFP or Myc 
tagged Pin1 expression system was set up.  
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3.2.1.3 Structure analysis of human Pin1 gene 
The 492bp of the coding sequence of Pin1 encodes a 163 amino acid protein 
(Figure 3.6b), which composed of α helices and β sheets within its two functional 
domains-PPIase domain and WW domain respectively, and these two domains are 
organized around a hydrophobic cavity. The N-terminal WW domain, residues 1-39, 
consists of a triple-stranded anti-parallel β sheet. The C-terminal PPIase domain, 
residue 45-163, forms the opposing wall of inter-domain cavity. In particular, a 
scaffolding alpha helix, α helices contribute totally 9 residues and to the wall and 
creates a deep internal surface opposite the WW domain’s hydrophobic pocket. In 
addition, the central scaffolding of the C-terminal PPIase domain consists of a 
four-stranded anti-parallel β sheet, and four alpha helices surround the flattened β 
barrel (Lu et al., 1996).  
 
3.2.2 Cloning of human Nurr1 gene 
3.2.2.1 Sub-cloning of Nurr1 into mammalian expression vectors  
pCMX-Nurr1 contains the cDNA-coding sequence of Nurr1 cloned into pCMX 
vector was kindly provided by Dr. Thomas Perlmann (Karolinska Institute, Sweden). 
In order to tag the Nurr1 with some reporter gene, a pair of primers (Table 3.1) with 
HindIII and BamHI restriction endonuclease sites flanked 5’ and 3’ ends of the coding 
sequence of Nurr1 respectively was designed. The original plasmid pCMX with Nurr1 
inserts was used as template for amplification of Nurr1 fragment with engineered 
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restriction endonuclease sites. After PCR amplification, the predicted 1800bp 
fragment (Figure 3.7) was cloned into the multiple cloning sites of a mammalian 
expression vector, pEGFPc1, within which the sequence of GFP was inserted on the 
5’ end of the multiple cloning sites.  
 
3.2.2.2 Sequencing and multiple alignment of human Nurr1  
10 randomly selected clones were initially digested with HindIII and BamHI and 
the prospective clones corresponding to the length of coding sequence of Nurr1 gene 
were transformed into TOP 10 competent cells. Selection of recombinant colonies on 
the basis of antibiotic resistance and the presence of the cDNA insert was confirmed 
for 3 of these colonies using DNA sequencing with sense and anti-sense sequencing 
primers (Table 3.1) for continuous fragments of Nurr1 double-stranded DNA. Finally, 
fiver positive clones (Figure 3.8) were isolated, and from them the related cDNA 
clones corresponding to the coding sequence of Nurr1 gene were identified. 
Comparison of the nucleotide sequence of Nurr1 with those available in 
GENBANK via BLAST showed that it had 100 percent match scores with the human 
sequences of Nurr1 in database (GENEBANK accession number AB019433). The 
restriction endonuclease sites-HindIII and BamHI flanked 5’ end and 3’ end of the 
coding sequence of Nurr1 gene was confirmed using alignment of engineered coding 
sequence of Nurr1 with the full-length homo sapiens Nurr1 cDNA sequence (Figure 
3.9a). Therefore, finally, a fusion protein of EGFP tagged Nurr1 expression system 
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was set up. 
 
3.2.2.3 Structure Analysis of human Nurr1  
Nuclear hormone receptors (NRs) functions as ligand-activated transcription 
factors that regulate gene expression involved in reproduction, development, and 
general metabolism (Steinmetz et al., 2001). All members of the NR super-family 
display a highly conserved structural organization (Figure 3.9c) (1) with an 
N-terminal region AB (which encodes activation function-1, AF-1) followed by the 
C-region (which encodes the DNA binding domain (DBD)), a linker region D, and the 
C-terminal E region. The DE region encodes the ligand binding domain (LBD) and a 
transcriptional domain, denoted as activation function-2 (AF-2) (Steinmetz et al., 
2001; Chawla et al., 2001). 
The 1797bp of the coding sequence of human Nurr1 encodes a 498 amino acid 
protein (Figure 3.9b), which is composed of a well conserved DNA binding domain 
and a somewhat less conserved carboxyl-terminal ligand binding domain (LBD). Two 
major regions essential for transcriptional activation, situated in the amino-terminal 
(AF1) and carboxyl-terminal (AF2) regions, respectively, have been identified by 
using mutated receptor derivatives in transcription assays in vivo and in vitro. The 
AF2 region plays a key role in the ligand-induced conformational transition of the 
LBD, which, upon ligand binding, results in activation of transcription. A region close 
to the carboxyl terminus contains an amphipathic α-helix, which has proven to be of 
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critical importance for ligand-induced transcriptional activation and is referred to as 
the AF2 core. Recent x-ray crystallographic studies have yielded a relatively clear 
understanding of the ligand-induced structural transition occurring within NRs. 
Notably, these analyses have demonstrated that ligand binding results in a 
conformational change involving repositioning of the AF2 core α-helix (Moras et al., 
1998; Nolte et al., 1998). Further, the Nurr1 LBD adopts a canonical protein fold 
resembling that agonist-bound, transcriptionally active LBDs in NRs, but the structure 
has two distinctive features. First, the Nurr1 LBD contains no cavity as a result of the 
tight packing of side chains from several bulky hydrophobic residues in the region 
normally occupied by ligands. Second, Nurr1 lacks a ‘classical’ binding site for 
co-activators. Despite these differences, the Nurr1 LBD can be regulated in 
mammalian cells. Notably, transcriptional activity is correlated with the Nurr1 LBD 
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Primer Name Plasmid Name Sequence Annealing 
Tm (0C) 
Pin1 (cds) pGEM-T (easy) 5’ atggcggacgaggagaagctgccg 3’ 71.4 
Pin1 (cds) pGEM-T (easy) 3’ tcactcagtgcggaggatgatgtg  5’ 66.3 
Pin1-XbalI pcDNA3.1-GFP/Myc 5’ tctagaatggcggacgaggagaagctg 3’ 69.2 
Pin1-XholI pcDNA3.1-GFP/Myc 3’ctcgagctcagtgcggaggatgatgtg 5’ 70.7 
NOT-HindIII pEGFPc1 5’gtttcacaagcttcgatgccttgtgttcaggcgca 
3’ 
71.7 
NOT-BamHI pEGFPc1 3’cttgggagggatccttagaaaggtaaagtgtc5’ 68.5 
 
Table 3.1 Sequence and properties of the primers Pin1 and Nurr1.  
The plasmid name, length and melting temperature (Tm) are indicated.   
 
 








Figure 3.1 Amplification of human Pin1 cDNA sequences.  
RT-PCR products of SH-SY5Y cells were used as templates a 492bp fragment was 
obtained using the Pin1-specific sense and anti-sense primers (lane 1, arrowed).  
 
Legend: M-Promega 100bp DNA ladder  
Lane 1-reaction product 1 
Lane 2-reaction product 2 
Lane 3-reaction product 3 
Lane 4-reaction product 4 
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 of these clones were subsequently selected for sequencing.  
0bp DNA marker  
 1              Lane 7-Colony 7 
 2              Lane 8-Colony 8 
 3              Lane 9-Colony 9 
 4              Lane 10-Colony 10 
 5              Lane 11-Colony 11 
 6              Lane 12-Colony 12 
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        M   L1   L2   L3   L4   L5   L6 
 
 




Figure 3.3 An illustration of restriction endonuclease digestion of selected 
colonies of Pin1-like inserts from pGEM-T easy vectors.  
The presence of the insert in the colonies was verified by double RE digestion. Where 
detected, it occurred as a 492bp product (lane 2 and lane 5), and the rest lanes were 
artificial ligation products (lane 1, lane 3, lane 4, lane 6). 
 
Legend:  M-Promega 100bp DNA marker 
         Lane 1-Colony 1            Lane 4-Colony 4 
         Lane 2-Colony 2            Lane 5-Colony 5 
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Figure 3.4 Direct colony screening by PCR.  
Colonies transformed with pcDNA3.1-GFP/Myc cloning vectors bearing the 492bp 
Pin1-like insert were screened and selected for using T7 and SP6 primers. In positive 
clones, a 492bp product was detected (lane1-3, lane 7, lane 10, lane 11, lane 13). 
Subsequently, these clones were selected for restriction endonuclease digestion and 
then for sequencing analysis.   
 
Legend: M-Promega 100bp DNA marker 
       Lane 1-Colony 1               Lane 10-Colony 10 
       Lane 2-Colony 2               Lane 11-Colony 11 
       Lane 3-Colony 3               Lane 12-Colony 12 
       Lane 4-Colony 4               Lane 13-Colony 13 
       Lane 5-Colony 5               Lane 14-Colony 14 
       Lane 6-Colony 6               Lane 15-Colony 15 
       Lane 7-Colony 7               Lane 16-Colony 16 
       Lane 8-Colony 8               Lane 17-Colony 17 
       Lane 9-Colony 9               Lane 18-Colony 18 
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 M   L1       L2       L3        L4        L5 
 







Figure 3.5 An illustration of restriction endonuclease digestion of recombinant 
colonies with Pin1-like cDNA inserts released from pcDNA3.1-GFP/Myc vectors.  
The presence of the insert in the colonies was verified by XbalI and XholI double 
enzymatic digestion. Where detected, it occurred as a 492bp product (lane 1 and lane 
5).  
 
Legend: M-Promega 100bp DNA marker   Lane 3-Colony 3 
       Lane 1-Colony 1                Lane 4-Colony 4 
       Lane 2-Colony 2                Lane 5-Colony 5 
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Pin1XbaIXholI   -6 TCTAGAATGG CGGACGAGGA GAAGCTGCCG CCCGGCTGGG AGAAGCGCAT  
Pin1CDS         -6 ......ATGG CGGACGAGGA GAAGCTGCCG CCCGGCTGGG AGAAGCGCAT  
 
Pin1XbaIXholI   45 GAGCCGCAGC TCAGGCCGAG TGTACTACTT CAACCACATC ACTAACGCCA  
Pin1CDS         45 GAGCCGCAGC TCAGGCCGAG TGTACTACTT CAACCACATC ACTAACGCCA  
 
Pin1XbaIXholI   95 GCCAGTGGGA GCGGCCCAGC GGCAACAGCA GCAGTGGTGG CAAAAACGGG  
Pin1CDS         95 GCCAGTGGGA GCGGCCCAGC GGCAACAGCA GCAGTGGTGG CAAAAACGGG  
 
Pin1XbaIXholI  145 CAGGGGGAGC CTGCCAGGGT CCGCTGCTCG CACCTGCTGG TGAAGCACAG  
Pin1CDS        145 CAGGGGGAGC CTGCCAGGGT CCGCTGCTCG CACCTGCTGG TGAAGCACAG  
 
Pin1XbaIXholI  195 CCAGTCACGG CGGCCCTCGT CCTGGCGGCA GGAGAAGATC ACCCGGACCA  
Pin1CDS        195 CCAGTCACGG CGGCCCTCGT CCTGGCGGCA GGAGAAGATC ACCCGGACCA  
 
Pin1XbaIXholI  245 AGGAGGAGGC CCTGGAGCTG ATCAACGGCT ACATCCAGAA GATCAAGTCG  
Pin1CDS        245 AGGAGGAGGC CCTGGAGCTG ATCAACGGCT ACATCCAGAA GATCAAGTCG  
 
Pin1XbaIXholI  295 GGAGAGGAGG ACTTTGAGTC TCTGGCCTCA CAGTTCAGCG ACTGCAGCTC  
Pin1CDS        295 GGAGAGGAGG ACTTTGAGTC TCTGGCCTCA CAGTTCAGCG ACTGCAGCTC  
 
Pin1XbaIXholI  345 AGCCAAGGCC AGGGGAGACC TGGGTGCCTT CAGCAGAGGT CAGATGCAGA  
Pin1CDS        345 AGCCAAGGCC AGGGGAGACC TGGGTGCCTT CAGCAGAGGT CAGATGCAGA  
 
Pin1XbaIXholI  395 AGCCATTTGA AGACGCCTCG TTTGCGCTGC GGACGGGGGA GATGAGCGGG  
Pin1CDS        395 AGCCATTTGA AGACGCCTCG TTTGCGCTGC GGACGGGGGA GATGAGCGGG  
 
Pin1XbaIXholI  445 CCCGTGTTCA CGGATTCCGG CATCCACATC ATCCTCCGCA CTGAGCTCGA  
Pin1CDS        445 CCCGTGTTCA CGGATTCCGG CATCCACATC ATCCTCCGCA CTGAGTAG..  
 
Pin1XbaIXholI  495 G.. 
Pin1CDS        495 ... 
 
 
Figure 3.6a Alignment of cloned Pin1.  
In pcDNA3.1-GFP/Myc vector Pin1 was flanked 5’-XbaI and 3’-XholI sites 
respectively with the full-length human cDNA sequence of Pin1. Region of homology 
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1      ATGGCGGACGAGGAGAAGCTGCCGCCCGGCTGGGAGAAGCGCATGAGCCGCAGCTCAGGC 
1        M  A  D  E  E  K  L  P  P  G  W  E  K  R  M  S  R  S  S  G   
 
61      CGAGTGTACTACTTCAACCACATCACTAACGCCAGCCAGTGGGAGCGGCCCAGCGGCAAC 
21        R  V  Y  Y  F  N  H  I  T  N  A  S  Q  W  E  R  P  S  G  N   
 
121      AGCAGCAGTGGTGGCAAAAACGGGCAGGGGGAGCCTGCCAGGGTCCGCTGCTCGCACCTG 
41        S  S  S  G  G  K  N  G  Q  G  E  P  A  R  V  R  C  S  H  L   
 
181      CTGGTGAAGCACAGCCAGTCACGGCGGCCCTCGTCCTGGCGGCAGGAGAAGATCACCCGG 
61        L  V  K  H  S  Q  S  R  R  P  S  S  W  R  Q  E  K  I  T  R   
 
241      ACCAAGGAGGAGGCCCTGGAGCTGATCAACGGCTACATCCAGAAGATCAAGTCGGGAGAG 
81        T  K  E  E  A  L  E  L  I  N  G  Y  I  Q  K  I  K  S  G  E   
 
301      GAGGACTTTGAGTCTCTGGCCTCACAGTTCAGCGACTGCAGCTCAGCCAAGGCCAGGGGA 
101        E  D  F  E  S  L  A  S  Q  F  S  D  C  S  S  A  K  A  R  G   
 
361      GACCTGGGTGCCTTCAGCAGAGGTCAGATGCAGAAGCCATTTGAAGACGCCTCGTTTGCG 
121        D  L  G  A  F  S  R  G  Q  M  Q  K  P  F  E  D  A  S  F  A   
 
421      CTGCGGACGGGGGAGATGAGCGGGCCCGTGTTCACGGATTCCGGCATCCACATCATCCTC 
141        L  R  T  G  E  M  S  G  P  V  F  T  D  S  G  I  H  I  I  L   
 
481      CGCACTGAGTAG 
161         R  T  E  *   
 
 
Figure 3.6b Nucleotide and the predicted amino acid sequence of cloned Pin1 
gene.  
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Figure 3.7 Amplification of Nurr1 cDNA engineered with restriction 
endonuclease sites by PCR.  
Legend: M-Promega 1kb DNA marker 
       Lane 1-Colony 1             Lane 4-Colony 4 
       Lane 2-Colony 2             Lane 5-Colony 5 
       Lane 3-Colony 3             Lane 6-Colony 6 
 








Figure 3.8 An illustration of restriction endonuclease digestion screening of 
recombinant colonies with Nurr1-like cDNA inserts.  
The presence of the insert in the colonies was verified by double enzymatic digestion. 
Where detected, it occurred as a 1797bp product (lane 1, lane 2, lane 5, lane 6 and 
lane 7). 
 Legend: M-Promega 1kb DNA marker       
       Lane 1-Colony 1 
       Lane 2-Colony 2                 Lane 5-Colony 5 
       Lane 3-Colony 3                 Lane 6-Colony 6 
       Lane 4-Colony 4                 Lane 7-Colony 7 
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Nurr1 pEGFPc1     -6 AAGCTTATGC CTTGTGTTCA GGCGCAGTAT GGGTCCTCGC CTCAAGGAGC  
Nurr1 CDS         -6 ......ATGC CTTGTGTTCA GGCGCAGTAT GGGTCCTCGC CTCAAGGAGC  
 
Nurr1 pEGFPc1     45 CAGCCCCGCT TCTCAGAGCT ACAGTTACCA CTCTTCGGGA GAATACAGCT  
Nurr1 CDS         45 CAGCCCCGCT TCTCAGAGCT ACAGTTACCA CTCTTCGGGA GAATACAGCT  
 
Nurr1 pEGFPc1     95 CCGATTTCTT AACTCCAGAG TTTGTCAAGT TTAGCATGGA CCTCACCAAC  
Nurr1 CDS         95 CCGATTTCTT AACTCCAGAG TTTGTCAAGT TTAGCATGGA CCTCACCAAC  
 
Nurr1 pEGFPc1    145 ACTGAAATCA CTGCCACCAC TTCTCTCCCC AGCTTCAGTA CCTTTATGGA  
Nurr1 CDS        145 ACTGAAATCA CTGCCACCAC TTCTCTCCCC AGCTTCAGTA CCTTTATGGA  
 
Nurr1 pEGFPc1    195 CAACTACAGC ACAGGCTACG ACGTCAAGCC ACCTTGCTTG TACCAAATGC  
Nurr1 CDS        195 CAACTACAGC ACAGGCTACG ACGTCAAGCC ACCTTGCTTG TACCAAATGC  
 
Nurr1 pEGFPc1    245 CCCTGTCCGG ACAGCAGTCC TCCATTAAGG TAGAAGACAT TCAGATGCAC  
Nurr1 CDS        245 CCCTGTCCGG ACAGCAGTCC TCCATTAAGG TAGAAGACAT TCAGATGCAC  
 
Nurr1 pEGFPc1    295 AACTACCAGC AACACAGCCA CCTGCCCCCC CAGTCTGAGG AGATGATGCC  
Nurr1 CDS        295 AACTACCAGC AACACAGCCA CCTGCCCCCC CAGTCTGAGG AGATGATGCC  
 
Nurr1 pEGFPc1    345 GCACTCCGGG TCGGTTTACT ACAAGCCCTC CTCGCCCCCG ACGCCCACCA  
Nurr1 CDS        345 GCACTCCGGG TCGGTTTACT ACAAGCCCTC CTCGCCCCCG ACGCCCACCA  
 
Nurr1 pEGFPc1    395 CCCCGGGCTT CCAGGTGCAG CACAGCCCCA TGTGGGACGA CCCGGGATCT  
Nurr1 CDS        395 CCCCGGGCTT CCAGGTGCAG CACAGCCCCA TGTGGGACGA CCCGGGATCT  
 
Nurr1 pEGFPc1    445 CTCCACAACT TCCACCAGAA CTACGTGGCC ACTACGCACA TGATCGAGCA  
Nurr1 CDS        445 CTCCACAACT TCCACCAGAA CTACGTGGCC ACTACGCACA TGATCGAGCA  
 
Nurr1 pEGFPc1    495 GAGGAAAACG CCAGTCTCCC GCCTCTCCCT CTTCTCCTTT AAGCAATCGC  
Nurr1 CDS        495 GAGGAAAACG CCAGTCTCCC GCCTCTCCCT CTTCTCCTTT AAGCAATCGC  
 
Nurr1 pEGFPc1    545 CCCCTGGCAC CCCGGTGTCT AGTTGCCAGA TGCGCTTCGA CGGGCCCCTG  
Nurr1 CDS        545 CCCCTGGCAC CCCGGTGTCT AGTTGCCAGA TGCGCTTCGA CGGGCCCCTG  
 
Nurr1 pEGFPc1    595 CACGTCCCCA TGAACCCGGA GCCCGCCGGC AGCCACCACG TGGTGGACGG  
Nurr1 CDS        595 CACGTCCCCA TGAACCCGGA GCCCGCCGGC AGCCACCACG TGGTGGACGG  
 
Nurr1 pEGFPc1    645 GCAGACCTTC GCTGTGCCCA ACCCCATTCG CAAGCCCGCG TCCATGGGCT  
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Nurr1 pEGFPc1    695 TCCCGGGCCT GCAGATCGGC CACGCGTCTC AGCTGCTCGA CACGCAGGTG  
Nurr1 CDS        695 TCCCGGGCCT GCAGATCGGC CACGCGTCTC AGCTGCTCGA CACGCAGGTG 
  
Nurr1 pEGFPc1    745 CCCTCACCGC CGTCGCGGGG CTCCCCCTCC AACGAGGGGC TGTGCGCTGT  
Nurr1 CDS        745 CCCTCACCGC CGTCGCGGGG CTCCCCCTCC AACGAGGGGC TGTGCGCTGT  
 
Nurr1 pEGFPc1    795 GTGTGGGGAC AACGCGGCCT GCCAACACTA CGGCGTGCGC ACCTGTGAGG  
Nurr1 CDS        795 GTGTGGGGAC AACGCGGCCT GCCAACACTA CGGCGTGCGC ACCTGTGAGG  
 
Nurr1 pEGFPc1    845 GCTGCAAAGG CTTCTTTAAG CGCACAGTGC AAAAAAATGC AAAATACGTG  
Nurr1 CDS        845 GCTGCAAAGG CTTCTTTAAG CGCACAGTGC AAAAAAATGC AAAATACGTG  
 
Nurr1 pEGFPc1    895 TGTTTAGCAA ATAAAAACTG CCCAGTGGAC AAGCGTCGCC GGAATCGCTG  
Nurr1 CDS        895 TGTTTAGCAA ATAAAAACTG CCCAGTGGAC AAGCGTCGCC GGAATCGCTG  
 
Nurr1 pEGFPc1    945 TCAGTACTGC CGATTTCAGA AGTGCCTGGC TGTTGGGATG GTCAAAGAAG  
Nurr1 CDS        945 TCAGTACTGC CGATTTCAGA AGTGCCTGGC TGTTGGGATG GTCAAAGAAG  
 
Nurr1 pEGFPc1    995 TGGTTCGCAC AGACAGTTTA AAAGGCCGGA GAGGTCGTTT GCCCTCGAAA  
Nurr1 CDS        995 TGGTTCGCAC AGACAGTTTA AAAGGCCGGA GAGGTCGTTT GCCCTCGAAA  
 
Nurr1 pEGFPc1   1045 CCGAAGAGCC CACAGGAGCC CTCTCCCCCT TCGCCCCCGG TGAGTCTGAT  
Nurr1 CDS       1045 CCGAAGAGCC CACAGGAGCC CTCTCCCCCT TCGCCCCCGG TGAGTCTGAT  
 
Nurr1 pEGFPc1   1095 CAGTGCCCTC GTCAGGGCCC ATGTCGACTC CAACCCGGCT ATGACCAGCC  
Nurr1 CDS       1095 CAGTGCCCTC GTCAGGGCCC ATGTCGACTC CAACCCGGCT ATGACCAGCC  
 
Nurr1 pEGFPc1   1145 TGGACTATTC CAGGTTCCAG GCGAACCCTG ACTATCAAAT GAGTGGAGAT  
Nurr1 CDS       1145 TGGACTATTC CAGGTTCCAG GCGAACCCTG ACTATCAAAT GAGTGGAGAT  
 
Nurr1 pEGFPc1   1195 GACACCCAGC ATATCCAGCA ATTCTATGAT CTCCTGACTG GCTCCATGGA  
Nurr1 CDS       1195 GACACCCAGC ATATCCAGCA ATTCTATGAT CTCCTGACTG GCTCCATGGA  
 
Nurr1 pEGFPc1   1245 GATCATCCGG GGCTGGGCAG AGAAGATCCC TGGCTTCGCA GACCTGCCCA  
Nurr1 CDS       1245 GATCATCCGG GGCTGGGCAG AGAAGATCCC TGGCTTCGCA GACCTGCCCA  
 
Nurr1 pEGFPc1   1295 AAGCCGACCA AGACCTGCTT TTTGAATCAG CTTTCTTAGA ACTGTTTGTC  
Nurr1 CDS       1295 AAGCCGACCA AGACCTGCTT TTTGAATCAG CTTTCTTAGA ACTGTTTGTC  
 
Nurr1 pEGFPc1   1345 CTTCGATTAG CATACAGGTC CAACCCAGTG GAGGGTAAAC TCATCTTTTG  
Nurr1 CDS       1345 CTTCGATTAG CATACAGGTC CAACCCAGTG GAGGGTAAAC TCATCTTTTG  
 
Nurr1 pEGFPc1   1395 CAATGGGGTG GTCTTGCACA GGTTGCAATG CGTTCGTGGC TTTGGGGAAT  
Nurr1 CDS       1395 CAATGGGGTG GTCTTGCACA GGTTGCAATG CGTTCGTGGC TTTGGGGAAT  
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Nurr1 pEGFPc1   1445 GATTGATTC  CATTGTTGAA TTCTCCTCCA ACTTGCAGAA TATGAACATC  
Nurr1 CDS       1445 GGATTGATTC CATTGTTGAA TTCTCCTCCA ACTTGCAGAA TATGAACATC  
 
Nurr1 pEGFPc1   1495 GACATTTCTG CCTTCTCCTG CATTGCTGCC CTGGCTATGG TCACAGAGAG  
Nurr1 CDS       1495 GACATTTCTG CCTTCTCCTG CATTGCTGCC CTGGCTATGG TCACAGAGAG  
 
Nurr1 pEGFPc1   1545 ACACGGGCTC AAGGAACCCA AGAGAGTGGA AGAACTGCAA AACAAGATTG  
Nurr1 CDS       1545 ACACGGGCTC AAGGAACCCA AGAGAGTGGA AGAACTGCAA AACAAGATTG  
 
Nurr1 pEGFPc1   1595 TAAATTGTCT CAAAGACCAC GTGACTTTCA ACAATGGGGG GTTGAACCGC  
Nurr1 CDS       1595 TAAATTGTCT CAAAGACCAC GTGACTTTCA ACAATGGGGG GTTGAACCGC  
 
Nurr1 pEGFPc1   1645 CCCAATTATT TGTCCAAACT GTTGGGGAAG CTCCCAGAAC TTCGTACCCT  
Nurr1 CDS       1645 CCCAATTATT TGTCCAAACT GTTGGGGAAG CTCCCAGAAC TTCGTACCCT  
 
Nurr1 pEGFPc1   1695 TTGCACACAG GGGCTACAGC GCATTTTCTA CCTGAAATTG GAAGACTTGG  
Nurr1 CDS       1695 TTGCACACAG GGGCTACAGC GCATTTTCTA CCTGAAATTG GAAGACTTGG  
 
Nurr1 pEGFPc1   1745 TGCCACCGCC AGCAATAATT GACAAACTTT TCCTGGACAC TTTACCTTTC  
Nurr1 CDS       1745 TGCCACCGCC AGCAATAATT GACAAACTTT TCCTGGACAC TTTACCTTTC  
 
Nurr1 pEGFPc1   1795 TAAGGATCC 
Nurr1 CDS       1795 TAA...... 
 
 
Figure 3.9a  Alignment of cloned Nurr1.  
In pEGFP vector Nurr1was flanked 5’-HindIII and 3’-BamHI sites respectively with 
the full-length human cDNA sequence of Nurr1. Region of homology between the 
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1         ATGCCTTGTGTTCAGGCGCAGTATGGGTCCTCGCCTCAAGGAGCCAGCCCCGCTTCTCAG 
1            M  P  C  V  Q  A  Q  Y  G  S  S  P  Q  G  A  S  P  A  S  Q   
 
61        AGCTACAGTTACCACTCTTCGGGAGAATACAGCTCCGATTTCTTAACTCCAGAGTTTGTC 
21           S  Y  S  Y  H  S  S  G  E  Y  S  S  D  F  L  T  P  E  F  V   
 
121       AAGTTTAGCATGGACCTCACCAACACTGAAATCACTGCCACCACTTCTCTCCCCAGCTTC 
41           K  F  S  M  D  L  T  N  T  E  I  T  A  T  T  S  L  P  S  F   
 
181       AGTACCTTTATGGACAACTACAGCACAGGCTACGACGTCAAGCCACCTTGCTTGTACCAA 
61           S  T  F  M  D  N  Y  S  T  G  Y  D  V  K  P  P  C  L  Y  Q   
 
241       ATGCCCCTGTCCGGACAGCAGTCCTCCATTAAGGTAGAAGACATTCAGATGCACAACTAC 
81           M  P  L  S  G  Q  Q  S  S  I  K  V  E  D  I  Q  M  H  N  Y   
 
301       CAGCAACACAGCCACCTGCCCCCCCAGTCTGAGGAGATGATGCCGCACTCCGGGTCGGTT 
101          Q  Q  H  S  H  L  P  P  Q  S  E  E  M  M  P  H  S  G  S  V   
 
361       TACTACAAGCCCTCCTCGCCCCCGACGCCCACCACCCCGGGCTTCCAGGTGCAGCACAGC 
121          Y  Y  K  P  S  S  P  P  T  P  T  T  P  G  F  Q  V  Q  H  S   
 
421       CCCATGTGGGACGACCCGGGATCTCTCCACAACTTCCACCAGAACTACGTGGCCACTACG 
141          P  M  W  D  D  P  G  S  L  H  N  F  H  Q  N  Y  V  A  T  T   
 
481       CACATGATCGAGCAGAGGAAAACGCCAGTCTCCCGCCTCTCCCTCTTCTCCTTTAAGCAA 
161          H  M  I  E  Q  R  K  T  P  V  S  R  L  S  L  F  S  F  K  Q   
 
541       TCGCCCCCTGGCACCCCGGTGTCTAGTTGCCAGATGCGCTTCGACGGGCCCCTGCACGTC 
181          S  P  P  G  T  P  V  S  S  C  Q  M  R  F  D  G  P  L  H  V   
 
601       CCCATGAACCCGGAGCCCGCCGGCAGCCACCACGTGGTGGACGGGCAGACCTTCGCTGTG 
201          P  M  N  P  E  P  A  G  S  H  H  V  V  D  G  Q  T  F  A  V   
 
661       CCCAACCCCATTCGCAAGCCCGCGTCCATGGGCTTCCCGGGCCTGCAGATCGGCCACGCG 
221          P  N  P  I  R  K  P  A  S  M  G  F  P  G  L  Q  I  G  H  A   
 
721       TCTCAGCTGCTCGACACGCAGGTGCCCTCACCGCCGTCGCGGGGCTCCCCCTCCAACGAG 
241          S  Q  L  L  D  T  Q  V  P  S  P  P  S  R  G  S  P  S  N  E   
 
781       GGGCTGTGCGCTGTGTGTGGGGACAACGCGGCCTGCCAACACTACGGCGTGCGCACCTGT 
261          G  L  C  A  V  C  G  D  N  A  A  C  Q  H  Y  G  V  R  T  C   
 
841       GAGGGCTGCAAAGGCTTCTTTAAGCGCACAGTGCAAAAAAATGCAAAATACGTGTGTTTA 
281          E  G  C  K  G  F  F  K  R  T  V  Q  K  N  A  K  Y  V  C  L   
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901       GCAAATAAAAACTGCCCAGTGGACAAGCGTCGCCGGAATCGCTGTCAGTACTGCCGATTT 
301          A  N  K  N  C  P  V  D  K  R  R  R  N  R  C  Q  Y  C  R  F   
 
961       CAGAAGTGCCTGGCTGTTGGGATGGTCAAAGAAGTGGTTCGCACAGACAGTTTAAAAGGC 
321          Q  K  C  L  A  V  G  M  V  K  E  V  V  R  T  D  S  L  K  G   
 
1021      CGGAGAGGTCGTTTGCCCTCGAAACCGAAGAGCCCACAGGAGCCCTCTCCCCCTTCGCCC 
341          R  R  G  R  L  P  S  K  P  K  S  P  Q  E  P  S  P  P  S  P   
 
1081      CCGGTGAGTCTGATCAGTGCCCTCGTCAGGGCCCATGTCGACTCCAACCCGGCTATGACC 
361          P  V  S  L  I  S  A  L  V  R  A  H  V  D  S  N  P  A  M  T   
 
1141      AGCCTGGACTATTCCAGGTTCCAGGCGAACCCTGACTATCAAATGAGTGGAGATGACACC 
381          S  L  D  Y  S  R  F  Q  A  N  P  D  Y  Q  M  S  G  D  D  T   
 
1201      CAGCATATCCAGCAATTCTATGATCTCCTGACTGGCTCCATGGAGATCATCCGGGGCTGG 
401          Q  H  I  Q  Q  F  Y  D  L  L  T  G  S  M  E  I  I  R  G  W   
 
1261      GCAGAGAAGATCCCTGGCTTCGCAGACCTGCCCAAAGCCGACCAAGACCTGCTTTTTGAA 
421          A  E  K  I  P  G  F  A  D  L  P  K  A  D  Q  D  L  L  F  E   
 
1321      TCAGCTTTCTTAGAACTGTTTGTCCTTCGATTAGCATACAGGTCCAACCCAGTGGAGGGT 
441          S  A  F  L  E  L  F  V  L  R  L  A  Y  R  S  N  P  V  E  G   
 
1381      AAACTCATCTTTTGCAATGGGGTGGTCTTGCACAGGTTGCAATGCGTTCGTGGCTTTGGG 
461          K  L  I  F  C  N  G  V  V  L  H  R  L  Q  C  V  R  G  F  G   
 
1441      GAATGGATTGATTCCATTGTTGAATTCTCCTCCAACTTGCAGAATATGAACATCGACATT 
481          E  W  I  D  S  I  V  E  F  S  S  N  L  Q  N  M  N  I  D  I   
 
1501      TCTGCCTTCTCCTGCATTGCTGCCCTGGCTATGGTCACAGAGAGACACGGGCTCAAGGAA 
501          S  A  F  S  C  I  A  A  L  A  M  V  T  E  R  H  G  L  K  E   
 
1561      CCCAAGAGAGTGGAAGAACTGCAAAACAAGATTGTAAATTGTCTCAAAGACCACGTGACT 
521          P  K  R  V  E  E  L  Q  N  K  I  V  N  C  L  K  D  H  V  T   
 
1621      TTCAACAATGGGGGGTTGAACCGCCCCAATTATTTGTCCAAACTGTTGGGGAAGCTCCCA 
541          F  N  N  G  G  L  N  R  P  N  Y  L  S  K  L  L  G  K  L  P   
 
1681      GAACTTCGTACCCTTTGCACACAGGGGCTACAGCGCATTTTCTACCTGAAATTGGAAGAC 
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1741      TTGGTGCCACCGCCAGCAATAATTGACAAACTTTTCCTGGACACTTTACCTTTCTAA 
581          L  V  P  P  P  A  I  I  D  K  L  F  L  D  T  L  P  F  *   
 
 
Figure 3.9b Nucleotide and the predicted amino acid sequence of cloned Nurr1 
gene.  















Figure 3.10 Depicted functional domains of Nurr1 which are homolog to other 
nuclear receptors.  
The locations of key functional domains in nuclear receptors are shown schematically. 
The box marked DNA represents the DBD. The box marked ligand represents the 
large C-terminal LBD. Dimerization and trans-activation (AF-2) functions are 
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As described in Chapter 1, NT2/D1 cell is valuable to study the dopamine neuron 
development and it is also a potential cell model of gene therapy for 
neurodegenerative diseases. In view of all these, and given the availability of Nurr1 
full-length cDNA and undifferentiated NT2/D1 cells, it is possible to make the 
relevant mammalian expression construct of Nurr1 and study its functions on the 
differentiating NT2 cell model. The present chapter investigated the presence of the 
transcription factor Nurr1 in mitotically active NT2 precursors as well as in several 
developmental stages of postmitotic NT2 neurons prepared via different time 
exposures to retinoic acid. Moreover, this study also showed that the over-expression 
of Nurr1 would result in TH and other DA markers up-regulation in differentiating 
NT2 neurons. However, the over-expression of Pin1 brought about the reverse effects 
on differentiating NT2 neurons, indicating that Pin1 might be involved in the 
development and differentiation of NT2 neurons by certain mechanisms such as 
blocking the downstream signaling pathways of RA-induced differentiation. The 
potential interaction between Pin1 and Nurr1 was examined; and the 
correlation/interaction between Pin1 and other target proteins involved in RA-induced 




4.2 Results and discussions 
4.2.1 Morphology of NT2/D1cells and NT2 differentiating cells 
NT2/D1 cells, a human teratocarcinoma cell line, were manipulated following 
retinoic acid treatment to yield highly pure cultures of neuronal cells (NT2 cells). The 
commitment of NT2 cells to a stable neuronal phenotype is irreversible as judged by 
the lack of mitotic activity or phenotypic reversion over a period of 1 month in culture 
(Pleasure et al., 1993). Furthermore, NT2 cells resemble primary neuronal cultures 
from rodents morphologically and in density of process outgrowth and, like primary 
neurons, go on to elaborate processes that differentiate into axons and dendrites. Here, 
the culture methods were modified from what have been established previously 
(Pleasure et al., 1992) to shorten the period of culture and the scheme was outlined in 
chapter of methodology. 
When undifferentiated NT2/D1 cells were initially plated, they appeared as 
phase-dark cells with a granular appearance or bearing occasionally very short neurite 
(Figure 4.1 A). Following around 4 weeks of RA treatment, the cells formed an 
extremely dense multilayered culture. The different stages/time courses of 
differentiating NT2 cells were then dispersed and re-plated at a lower density to 
release the NT2 cells buried in the midst of the many layers of cells. Following this 
treatment, the NT2 cells were seen as small phase-bright cells above a layer of flat 
cells (Figure 4.1 B). When these cultures were examined using phase-contrast 
microscopy at various times (Figure 4.1 B-F), progressive development of extensive 
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neurite networks covering the entire culture dish was observed. Fine, un-tapering long 
processes, similar to the axonal processes described in primary neuronal cultures, 
were also evident. As shown in Figure 4.1 F, single cells in these cultures elaborated 
processes that were thick at the base and tapered progressively from the cell body. 
Additionally, thin non-tapering processes arose from these cells. As seen from Figure 
4.1 B, many cells have begun to elaborate rudimentary processes similar to a number 
of human neuroblastoma cell lines (Pleasure 1992). These two morphologically 
distinct types of processes resembled the dendrites and axons, respectively, of primary 
cultures of CNS and PNS neurons. During the period of extensive process outgrowth, 
the NT2 cells displayed growth cones typical of primary cultures of neurons from 
various regions of the nervous system. Another consistent feature of pure NT2 cells 
was their motility. Initially, NT2 cells were evenly dispersed over the entire surface of 
the culture dish (Figure 4.1 A, B), but over time they migrated together to form 
cellular aggregates with large inter-connecting fascicles of axons (Figure 4.1 D). As 
for the reproducibility of the differentiating NT2 cells, over a number of trials (n=6), 
beginning with a T25 culture flask or 10cm petri-dish seeded with around 6ⅹ105 
NT2 cells, treated with 10uM RA for 4-5 weeks, and then taken through re-plate 1 
and 2, most of the differentiated cells were reproduced by this method. Moreover, the 
differentiated NT2 cells can be cryo-preserved and later recovered and further treated 




 4.2.2 Over-expression of Nurr1 and Pin1 in differentiating NT2 cells 
Transient transfection of NT2 cells was carried out using the Lipofectamine 
transfection reagents (Invitrogen, USA) according to the recommended procedure. 
Lipofectamine precipitate was obtained by diluting 4 µg (for 6-well plate, per well), 8 
µg (for T25 culture flask), or 12 µg (for 10 cm Petri-dish) respectively of plasmid 
DNA containing EGFP-Nurr1, CMV Nurr1, GFP-Pin1 or empty vector in non-serum 
culture medium and mixed with optimized dilution of the transfection reagent. The 
mixture was incubated for 20 min at room temperature, and then was added to the 
transfection mix in appropriate culture container with low serum medium and 
incubated at 37  ℃ for 4-6 h to allow transfection. At the end of the 4-6 h, the 
transfection medium was replaced with fresh normal culture medium and cells were 
maintained for up to 48 h to achieve optimal expression. Within 2 days after every 
transient transfection of a Nurr1 or Pin1 expression vector at certain time point of 
all-trans-RA presence, the morphology of NT2 cells were visualized by 
phase-contrast microscopy and the expression pattern of Nurr1 or Pin1 were 
visualized by fluorescent microscopy. 
 
4.2.2.1 Fluorescent detection of Nurr1 and Pin1 in differentiating NT2 cells 
Fluorescent images (Figure 4.2 A and B) show the distribution of over-expressed 
Nurr1 or Pin1 proteins respectively in randomly selected all-trans-RA treated neurons 
at different time courses. These images indicate that Nurr1 was only localized in 
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nucleus as GFP signal was visualized only in cell body of the single neuron; whereas 
the distribution of Pin1 was mainly in the nucleus and also located in the cytoplasm as 
GFP signal was visualized not only in cell body but also in neurite and dendrites 
throughout the whole NT2 cell. 
Therefore, expression of these signals demonstrated that the exogenously 
expressed Nurr1 and Pin1 overlapped with their endogenous transcripts and localized 
in specific sub-cellular organelles according to the literature reported else where (Law 
et al., 1992; Lu 2004). 
Optimistically, the transfection efficiencies of the construct(s) containing Nurr1 
varied from 15-25%, while the transfection efficiencies of the construct(s) containing 
Pin1 or GFP/EGFP varied from 20-35% and 30-40%, respectively. The above 
optimization was carried out on difference batches of NT2 cells using the same 
concentration of the above DNA(s) and the same dosage of LipofectamineTM 2000 
transfection reagent. 
 
4.2.2.1.1 Nurr1 over-expression in the absence of retinoic acid induces NT2/D1 
cell differentiation 
Within 3 days after transient transfection of a Nurr1 expression vector, a mature 
neuronal morphology, characterized by long, commonly bipolar neurite, was induced. 
This morphology could be clearly visualized by comparing with the morphology of 
undifferentiated NT2/D1 cells (Figure 4.2 A, B). The differentiating NT2/D1 cells 
(labeled as NT2) were counted and analyzed statistically 3 days later (Figure 4.2 C) 
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compared to non-transfected NT2/D1 cells treated with retinoic acid. For example, as 
for day 1, Figure 4.2 shows that the percentage of Nurr1 over-expressed NT2 cells is 
above 10% more than that of mock-transfected NT2 cells. Moreover, for the rest days 
examined, the trends are consistent. Therefore, it indicates that over-expressed Nurr1 
enhanced the NT2/D1 cell differentiation significantly. 
 
4.2.2.1.2 Pin1 over-expression in the absence of retinoic acid enhances NT2/D1 
cells proliferation 
Within 3 days after transient transfection of a Pin1 expression vector, NT2/D1 
cells retained the usual round cell morphology (Figure 4.2 B). Figure 4.2 shows that 
on day 1, the percentage of Pin1 over-expressed NT2 cells is much lower than that of 
mock-transfected NT2 cells by at leas 10 percent; while the difference is even higher 
between the percentage of Pin1 over-expressed NT2 cells and Nurr1 over-expressed 
NT2 cells. Therefore, it is revealed that most of Pin1-overexpressing NT2 cells were 
undergoing proliferation and growing faster compared to that of the non-transfected 
NT2/D1 cells; whereas, most of Nurr1-overexpressing NT2 cells were undergoing 
differentiation (Figure 4.2 C).  
 
4.2.3 Cell cycle analysis of differentiating NT2 cells 
Mechanisms that regulate cell differentiation are often intimately linked to the 
control of cell proliferation. Thus, as reported previously, Pin1 modulates cell growth 
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by correlating with cyclinD1, which is an important cell-cycle regulator that is known 
to have a key role in many cell types (Wulf et al., 2001; Liou et al., 2002). In contrast, 
as reported else where, over-expression of Nurr1 promotes cell cycle arrest at the G1 
phase in MN9D, a dopaminergic cell line (Castro et al., 2001). 
Here, flow cytometric analysis was carried out on 10,000 gated EGFP or 
GFP-expressing NT2 cells using a FACSCalibur flow cytometer equipped with 
winMDIv2.8 or Summit 3.3 v1028 software (Becton Dickinson).  
The various vectors containing Nurr1, Pin1 or EGFP genes all contain a CMV 
promoter, which would usually be inactivated intracellularly within one week. And 
the cell sorting experiments were carried out after 48 hr post-transfection to confirm 
that these transgenes were ultimately and properly expressed intracellularly when 
applied to cell cycle analysis. Therefore, based on the above considerations, the 
author believes that in general the different expression patterns of cell cycle regulated 
proteins were the direct effects of over-expression of Nurr1 or Pin1, respectively. 
 
4.2.3.1 Nurr1 induced NT2 cells arrested in G1 phase 
To determine whether the decrease in proliferation was caused by an arrest in cell 
cycle, the relative DNA contents of NT2 cells transfected with expression vectors for 
Nurr1 or EGFP were measured using FACS. Forty eight hours after transfection of 
various expression vectors, a substantial increase or decrease in the number of cells at 
the G1 phase of cell cycle was detected at different stages/time courses of 
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differentiating NT2 cells (Figure 4.3 A, middle column of panel), and percentage of 
cells in G0, G1, S and G2/M phases were statistically calculated (Figure 4.3 B). 
The analysis implied that Nurr1 inhibits proliferation by inducing G1 arrest in 
NT2 differentiating cells exposed to retinoic acid. In addition, Nurr1 was able to 
induce G1 arrest in the parental NT2/D1 cells in the absent of retinoic acid without 
promoting any obvious morphological differentiation (Figure 4.3 A, left and right 
column of panels (a)). 
 
4.2.3.2 Pin1 promotes NT2 cells mitosis 
To determine whether the increase in proliferation was caused by cell cycle shift 
to mitotic phases, the relative DNA contents of NT2 cells transfected with expression 
vectors for Pin1 or GFP were measured using FACS. Forty eight hours after 
transfection of various expression vectors, a substantial increase or decrease in the 
number of cells at the G1 phase of cell cycle at the G1 phase of cell cycle was detected 
at different stages/time courses of differentiating NT2 cells (Figure 4.3) A, right 
column of panel), and percentage of cells in G0, G1, S and G2/M phases were 
compared (Figure 4.3 B).  
The data show that Pin1 promotes NT2 cell proliferation by inducing S, or G2/M 
phases arrest in NT2 differentiating cells exposed to retinoic acid. In addition, Pin1 
was able to induce S or G2/M arrest in the parental NT2/D1 cells in the absent of 
retinoic acid (Figure 4.3 A, compare left and right columns of panel a).  
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4.2.4 Cell cycle regulation protein expression patterns in Nurr1 or 
Pin1 over-expressing NT2 cells 
Cell proliferation and differentiation are highly coordinated during normal 
development. The cell cycle is controlled by the activities of a family of 
serine/threonine protein kinases called cyclin-dependent kinases (Cdks). Progression 
through the G1 phase is controlled by the activities of CDK4 and CDK6, which 
associate with the D-cyclins (D1, D2 and D3), and CDK2, which associates first with 
cyclin E and then later in S phase with cyclin A (Steinman 2002). Whereas, functional 
differences are known among the D-, E-, and A-dependent kinases, differences 
between the two cyclin D-dependent kinases, CDK4 and Cdk6 have not been reported. 
It was reported previously by Matushansky I. et al. that the activities of Cdk4 and 
Cdk6 are differentially regulated during reprogramming of MEL (murine 
erythroleukemia) cells to terminal differentiated. They also showed that the activity of 
Cdk4, but not Cdk6, is crucial for the proliferation of MEL cells during the late stages 
of differentiation, once the cells have already been reprogrammed (Matushansky et al., 
2000). Later, they reported that Cdk6, but not Cdk4, participates in the earlier 
reprogramming decision by demonstrating that down-regulation of Cdk6 is required 
for MEL cells to reinitiate differentiation (Matushansky et al., 2003). Further, 
terminally differentiated neurons are post-mitotic and become growth arrested in the 
G0 or G1 phase of cell cycle controlled by the protein family of cyclin-dependent 
kinases (Cdks), the activation of which are positively regulated by forming complexes 
with cyclins, or negatively, by binding to Cdk inhibitors (Figure 4.4). The expression 
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of Cdks is differentially regulated during neuronal differentiation and the activities of 
Cdks in neuronal cells are correlated with the commitment of neurons to withdraw 
from the cell cycle (Hayes et al., 1991).  
A key finding in the work reported here is the observation of expression pattern 
of CDK6 and other cell cycle regulatory proteins in the Nurr1-overexpressing or 
Pin1-overexpressing NT2 cells differentiating into CNS cells terminally; and 
obviously Nurr1 and Pin1 have reverse functions during the processes of NT2 cell 
proliferation and differentiation, which are inversely correlated. 
 
4.2.4.1 CyclinD1 and Cdk6 are down-regulated after Nurr1 over-expression 
Treatment of NT2 cells with retinoic acid, an inducer of differentiation leads 
initially to the production of cells that are not overtly differentiated but that are 
irreversibly committed to differentiate. The committed cells require the presence of 
the inducer to execute the terminal differentiation program. Committed cells appeared 
obviously 5 days after initiation of RA treatment and continued to differentiate as 
long as exposed to the inducer. After committing to differentiation, NT2 cells 
continue to proliferate for several division cycles at the early stages of the 
differentiation. The commitment step defines a transition from continuously dividing 
neuronal progenitor cells to cells that are able to undergo only a limited number of 
cell cycles. To investigate possible involvement of cell cycle regulator in this 
transition, the expression levels of the cyclinD1 and Cdk6 were assayed during 
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RA-induced differentiating NT2 cells, and/or Nurr1-overexpressing NT2 cells at the 
indicated times of differentiation. The levels of cyclinD1 and Cdk6 were relatively 
constant during the first 3 weeks of differentiation under Nurr1 over-expression (5-22 
d) but after around 3 weeks, then it declined as cells undergoing terminal arrest 
(Figure 4.5 A, panel a). The late decline in cyclinD1 and Cdk6 is not because of a 
decline in the amounts of the catalytic subunit neither of the enzymes nor in the 
amounts of the cyclin regulatory subunits (Matushansky et al., 2000). It is supposed 
that this late decline in cyclinD1 and Cdk6 is because of induction of several Cdk 
inhibitors as reported in the relevant literature (Matushansky et al., 2000). In this 
study, compared to the non-transfected NT2 cells, the decline in cyclinD1 and Cdk6 
are more obvious in Nurr1-overexpressing NT2 cells (Figure 4.5 A, panel (a) and (b)). 
These results are consistent to the previous data from FACS, indicating that Nurr1 
will induce cell cycle arrest at G1 phase. The mechanism of Nurr1-induced cell cycle 
are presumably dependent on the strong conservation of the DNA binding domains of 
Nurr1 and its closely related sisters NGFI-B and Nor1, which are composed of the 
Nur77 subfamily of nuclear receptors, and on their ability to recognize similar DNA 
binding sequences and thereby trans-activate and promote the transcription of certain 
genes such as TH to initiate dopaminergic neuron development (Castro et al., 2001; 
Kim et al., 2003). However, it should be noted that among the members of the Nur77 
subfamily, only Nurr1 is expressed in the developing midbrain (Castro et al., 2001). 
This implicated that Nurr1 mainly influenced developing DA cells, as well as the 
comparably minor effects of NGFI-B and Nor1 to in the control of differentiation and 
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growth at other sites where these receptors are expressed in vivo. 
 
4.2.4.2 CyclinD1 and Cdk6 are up-regulated after Pin1 over-expression 
The foregoing observations of cyclinD1 and Cdk6 expression patterns were 
reversely showed in Pin1 over-expressing NT2 cells undergoing differentiation. Even 
though NT2 cells were exposed to the inducer of differentiation constantly, after Pin1 
over-expression, the proliferation was executed overwhelmingly rather than 
differentiation. As long as Pin1 is over-expressed in NT2 cells, it could break the 
balance of cell proliferation and differentiation coordinated during the initial 
development and drove most of the cells in to mitotic cycles. Highly proliferating 
cells first appeared 16 days after initiation of RA treatment and by 30 days most cells 
had become committed into post-mitotic cycles (Figure 4.5 B, panel (a) and (b)), 
demonstrating the increased expression levels of cyclinD1 and Cdk6. The 
up-regulation of cyclinD1 and Cdk6 could thus be closely regulated by the 
over-expression of Pin1. Previous literature revealed that in normal tissues (except in 
neurons), Pin1 expression is associated with cell proliferation, and that it is 
over-expressed prevalently in human cancer cells (Liou et al., 2003). Analysis of 
molecular markers for cancer revealed a close correlation between Pin1 and cyclin D1 
(Wulf et al., 2001). Because cyclin D1 is an important cell-cycle regulator that is 
known to have a key role in the development of many cancers, this connection has led 
to a series of in vitro and in vivo studies that demonstrate an essential role of Pin1 in 
 87
Chapter IV 
regulating cyclinD1 expression and turnover through multiple mechanisms (Liou et 
al., 2002; Wulf et al., 2001). 
Furthermore, as indicated in Figure 4.4 that cyclinB is an important cell cycle 
regulator correlated in the transition from S phase to G2 phase, the protein extracts of 
transfected NT2 cells with Nurr1 over-expression or Pin1 over-expression were 
assayed by immunoblotting with anti-cyclinB1 antibody. The expression level of 
cyclinB1 was very low or hard to detect in Nurr1 overexpressing NT2 cells (Figure 
4.5A, panel (c)). In contrast, after 16 days of exposure to retinoic acid and Pin1 
transfection, the activity of cyclinB1 in Pin1 overexpressing NT2 cells was 
up-regulated much overtly (Figure 4.5B, panel (c)). 
Taken together, these results have implicated that Nurr1 induces NT2 cells arrest 
in postmitotic phase, whereas Pin1 promotes NT2 cells to undergo continuous 
division and drives them into pre-mitotic phases, which is a typical characteristic of 
cell proliferation. In summary, the over-expression of Pin1 can cooperate with 
cyclinB1 together with other cell cycle regulation proteins to cause a significant delay 
in final cell cycle withdrawal, resulting in extended proliferation of initially 
committed differentiating NT2 cells.  
 
4.2.5 Dopamine neuron marker protein expression patterns in Nurr1 
and/or Pin1 over-expressing NT2 cells 
Previous studies estimated that NT2 cells in the previously described culture 
systems made up a mirror component of the total cell population (Andrew 1984). 
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These cells were shown to express neuronal intermediate filament family proteins, 
such as NF-66 but not peripherin, the two more recently described members of the 
neuronal intermediate filament family. NT2 cells, therefore, may resemble CNS 
neurons because NF-66 is abundant only in the CNS, and peripherin is found in 
virtually all PNS neurons (Misuita et al., 2003). NT2 cells also expressed several 
neuronal MAPs, including tau, but lack a newly cloned high molecular weight tau 
isoform that is expressed in most, if not all, immature and mature PNS neurons but 
not in CNS neurons. Furthermore, NT2 cells also expressed neuronal membrane or 
membrane-associated antigens. For example, NCAM, a cell surface molecule 
frequently expressed by neurons and neuronal neoplasms, is highly expressed in NT2 
cell (Pleasure et al., 1992). Most recent studies revealed that NT2 cells possess 
immunocytochemically detectable markers typical of dopaminergic ventral 
mesencephalic neurons, including tyrosine hydroxylase (TH), dopamine transporter 
(DAT), dopamine receptor type 2 (D2DR), and aldehyde dehydrogenase (ADH-2) 
(Zigova et al., 2000). Later, Misiuta I. et al. (2003) indicated that Nurr1 would be 
expressed in 3, 4, or 5-week RA-induced NT2 neurons.  
Here, I sought to examine the influence of exogenous Nurr1 or Pin1 in 
differentiating NT2 cells. The following immunocytochemical and immunoblotting 
analyses would indicate the different expression pattern of dopaminergic neuron 




4.2.5.1 Dopamine transporter (DAT), tyrosine hydroxylase (TH), and dopamine 
receptor type 2 (D2DR) are up-regulated in Nurr1-over-expressed NT2 cells, 
whereas down-regulated in Pin1-over-expressed NT2 cells 
By using immunocytochemical assays, the pattern of TH, DAT and D2DR were 
analyzed during NT2 cell differentiation induced by retinoic acid. Nurr1 transcripts 
were clearly detectable from the indicated time-point examined in differentiating NT2 
cells, when endogenous DAT (located as a trans-member protein), TH (located 
mainly in nucleus) and D2DR were also detectable (Figures 4.6 and 4.8). The number 
of DAT-or TH-positive cells showed a sharp increase in Nurr1-over-expressed NT2 
cells exposed to retinoic acid in comparison to those of DAT- or TH-positive cells in 
differentiating NT2 cells or mock transfected cells (Figure 4.7 A, Figure 4.9 A). 
Whereas, in Pin1-over-expressed NT2 cells exposed to retinoic acid, the number of 
DAT- or TH-positive cells did not increase too much, neither did they decrease 
(Figure 4.7 B, Figure 4.9 B). This phenomenon is mainly due to that, as indicated in 
the experimental design, the NT2 cells were always under the exposure of retinoic 
acid regardless of whether they were also transfected with Nurr1 or Pin1 exogenous 
genes. Therefore, the over-expression of Pin1 blocked the pathways of dopaminergic 
cells differentiation by certain mechanism(s); however, retinoic acid was still a 
powerful inducer, which promotes the NT2 cells differentiate into CNS cells 
including dopaminergic cells by counteracting the effects from Pin1 over-expression. 
In order to ascertain these dopaminergic neuron marker genes expression patterns 
during NT2 cell development, immunoblotting assays were carried out to detect the 
endogenous levels of TH, DAT and D2DR respectively. As demonstrated in Figure 
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4.10, the expression levels of TH, DAT and D2DR were constantly increased in 
Nurr1-overexpressing NT2 cells and also up-regulated in differentiating NT2 cells 
without transfection (Figure 4.10 A, B and C, panel (a)). In contrast, in 
Pin1-overexpressing NT2 cells, the expression levels of TH, DAT and D2DR were 
relatively decreased or not constantly increased compared to those of mock 
transfected NT2 cells (Figure 4.10 A, B and C, panel (c)) and to those of 
Nurr1-overexpressing NT2 cells (Figure 4.10 A, B and C, panel (a)), even though the 
differentiating NT2 cells were always exposed to retinoic acid. This implicated that 
retinoic acid is an external influences for neuronal progenitor cell differentiation into 
CNS cells; however, it is not an indispensable requirement for neuron development. 
Furthermore, the internal positive or negative influences would cooperate with the 
external ones together to activate either the signaling pathways of neuron 
development or through other mechanisms of inducing neuron development.  
 
4.2.6 Phosphorylation is involved in Nurr1 or Pin1 over-expressing 
NT2 differentiating neurons 
As reported elsewhere (David et al., 1993), Nur77, which is a sister of Nurr1 also 
belonging to NGFIB subfamily of nuclear receptors, can be auto-phosphorylated. As 
demonstrated in Figure 4.14A panel (a), the discrete bands of endogenous Nurr1 in 
differentiating NT2 cells indicated that Nurr1 was auto-phosphorylated or 
phosphorylated by certain protein kinases. However, in Pin1-overexpressing NT2 
cells, the behavior of endogenous Nurr1 was different compared to that in mock- 
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transfected NT2 cells. It was shown that the discrete bands, which indicated the 
phosphorylation of Nurr1, disappeared in Pin1-overexpressing NT2 cells. Regarding 
how Pin1 alleviated the phosphorylation of Nurr1 endogenously, on one hand, it is 
supposed here that Pin1 would bind directly to its substrate which is a potential kinase 
for Nurr1 phosphorylation and isomerized its conformation sequestered either in cis 
or trans form according to its energetic favour. Moreover, the isomerization of such 
kinase would have profound effects on the function and regulation of Nurr1 and 
thereby blocked the Nurr1-induced signaling pathway(s) in neuron development. On 
the other hand, Nurr1 itself has Ser/Thr-Pro motifs and Pin1-type PPIase are so far the 
only enzymes that catalyze efficiently the isomerization of pSer/Thr-Pro motifs. It is 
possible that Pin1 would bind directly to Ser/Thr-Pro motifs of Nurr1 and change the 
potential of Nurr1 phosphorylation via isomerizes such motifs. How does Nurr1 
phosphorylation or auto-phosphorylation occur is still a mystery. As for the internal 
mechanisms of Nurr1 phosphorylation, it was not explored and clarified in this 
chapter and remained as part of the future work. 
 
4.2.6.1 Phosphorylated tyrosine hydroxylase (phosphor-TH) is up-regulated in 
Nurr1-over-expressed NT2 cells, whereas down-regulated in Pin1-over-expressed 
NT2 cells 
To further explore the phosphorylation phenomena occurred in NT2 cells 
differentiation, more immunoblotting assays were carried out to detect the intrinsic 
phosphorylation relevant to dopaminergic neuron development. It was chosen to use 
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phosphor-tyrosine hydroxylase antibody to examine the behavior of TH in 
differentiating NT2 cells under different circumstances. It was indicated from Figure 
4.11 that at the different stages of Nurr1 overexpressing NT2 cells, the expression 
levels of phosphorylated tyrosine hydroxylase were gradually increased. Especially, at 
the late stages after 30 days of differentiation, the expression level of phosphor-TH 
was much prominent. Also, in mock-treated cells, the levels of phosphor-TH were 
detectable but not increased that evidently. In contrast, in Pin1-overexpressing NT2 
cells, as shown from Figure 4.11 (B), the empty blot demonstrated that after Pin1 
over-expression, the endogenous level of phosphor-TH was sharply decreased till to 
the level may not be detected by western blotting assay. It might be due to that Pin1 
directly interact with TH and induced the conformational changes of TH; therefore, 
such residues as serine and threonine could not expose to protein kinases or relevant 
kinases and be phosphorylated intracellularly. Optionally, it is possible that Pin1 
blocked the transcriptional regulation of TH via interacting directly with Nurrr1; 
therefore, Nurr1 could not bind to the certain element of the TH gene and 
transactivates the promoter activity of TH. 
These results are supportive to the findings of Nurr1 phosphorylation. As for the 
correlation between Nurr1 and TH, it was previously reported that TH catalyzes the 
first and rate-limiting step of catecholamine synthesis and its expression is necessary 
for neurotransmitter specification of all catecholaminergic neurons, while dopamine 
beta-hydroxylase (DBH) is essential for the noradrenergic phenotype. Most important, 
Nurr1 directly transactivates the promoter activity of the TH gene in a cell 
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type-dependent manner, while it does not regulate the DBH promoter. Consistently, 
only the TH promoter contains multiple sequence motifs homologous to the known 
Nurr1-binding motif, NBRE (Kim et al., 2003). From other perspectives, the results 
presented here are valuable for further exploring the Pin1 gene function in 
dopaminergic neuron development at multiple levels other than an isomerase. It is 
possible that Pin1 would modulate the expression of neurotransmitter specification of 
all dopaminergic neurons by blocking the upstream signaling pathway(s) related to 
Nurr1 and TH expression. There is still no clue to identify the influences of Pin1 on 
other signaling pathway(s) correlating with homeobox genes such as Pitx3 and 
Lmx1b which comes forth earlier than TH and Nurr1 during dopaminergic neuron 
development (Zetterstrom et al., 1996). 
 
4.2.7 Nurr1 cooperates with Pin1 in differentiating NT2 cells 
From previous literature about Pin1, it is fascinating that Pin1 plays diverse roles 
at multiple levels on the arrays of cellular processes. Importantly, aberrant Pin1 
function has implicated in several human diseases’ such as human cancers and 
Alzheimer’s disease (Wulf et al., 2005). However, the mechanisms of Pin1 functions 
in cancer cells and neurons are relatively different and still have remained unknown. 
It is notable that Pin1-deficient mice develop age-dependent neuron-degeneration. 
Given these previous reports and apparently related cellular functions of Pin1 studied 
in the present work, it is valuable to further explore the mechanisms of Pin1 involved 
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in dopaminergic neuron development. The following experiments were carried out to 
further study the correlation of Nurr1 and Pin1 on differentiating neuronal progenitor 
cell model. 
  
4.2.7.1 Nurr1 co-localizes with Pin1 in differentiating NT2 cells 
Previous sub-cellular localization of Nurr1 and Pin1 revealed that Nurr1 is 
always sequestered in nucleus and Pin1 both in nucleus and cytoplasm. Only under 
special circumstance does Pin1 outflow from nucleus and therefore there is a 
proportionally more cytoplasm localization of Pin1 in the diseased brains (Thorpe et 
al., 2004). In here, the localization of Nurr1 and Pin1 respectively were studied during 
NT2 cell differentiation.  
The previous immunofluorescent assays confirmed the localization of Nurr1 and 
Pin1 as reported elsewhere. In normal differentiating NT2 cells, Nurr1 localized in 
nucleus as demonstrated by GFP signal in cell body where nucleus aggregates, 
whereas GFP signal of Pin1 displayed throughout the whole cells.  
The following strategy was generated to examine whether Nurr1 and Pin1 share a 
similar expression pattern in the differentiating NT2 cells and whether expression of 
Nurr1 is under the influence or modulation of Pin1 activation. The Pin1 gene inserted 
in to a GFP tagged plasmid was delivered into differentiating NT2 cells by transient 
transfection and after 48 hr the transcript reached the best expression. At this time, the 
cells were fixed and applied to the immunocytochemical assays using Nurr1 antibody. 
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It was shown on Figure 4.12 that the exogenous Pin1 presenting GFP signal was 
overlapping with endogenous Nurr1 stained as red spots in the nucleus, while Nurr1 
and Pin1 seemed to co-localize in the nucleus at different stages of NT2 cells 
development.  
 
4.2.7.2 Nurr1 interacts with Pin1 physically  
NT2 cells were used to analyze how Nurr1 might contribute to the differentiation 
of dopaminergic neurons. As shown previously, Nurr1 induces morphological 
differentiation of NT2 cells by arresting cells in G1 phase. In contrast, over-expression 
of Pin1 alone was efficient in promoting NT2 cell proliferation. The reverse cellular 
functions of Nurr1 and Pin1 together with their co-localization induced the further 
speculation that functional co-operation in NT2 cell might reflect direct 
protein-protein interaction between Nurr1 and Pin1. Indeed, the following 
observations demonstrated that these two proteins physically interact with one another. 
Interaction was detected by co-immunoprecipitation from cell extracts of SH-SY5Y 
cells expressing Nurr1, Pin1, or both (Figure 4.13). Different transfection patterns 
were performed and immunoprecipitated using a polyclonal rabbit Pin1 specific 
antibody and analyzed using a mouse antibody against GFP-tag. EGFP-Nurr1 was 
detected in transfected SH-SY5Y cells and specific 100 kDa band was recognized as 
the fusion protein of EGFP and Nurr1 by GFP antibody. The obtained results (Figure 
4.13 A) showed that the Pin1 specific antibody interacted only with the 55 kDa 
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protein corresponding to GFP-Pin1 (Figure 4.13 A, right panel, lane 2). The proteins 
associated to the agarose beads conjugated with Pin1 antibody was then used to 
perform a Pin1 pull-down assay (Figure 4.13 A, left panel). The obtained pull-down 
samples were analyzed by immunoblotting and Nurr1 was detected using a specific 
GFP antibody. As expected, the antibody against GFP recognized both products-55 
kDa and 100 kDa, respectively, to GFP-Pin1 and EGFP-Nurr1 (Figure 4.13 A, left 
panel, lane 1). Protein extract from co-transfection of an empty EGFP vector and 
Myc-Pin1 vector (Figure 4.13, left panel, lane 3) were incubated with agarose Pin1 
bead and analyzed by GFP specific antibody. Expectably, no band was found on the 
bead. This result ruled out the possibility that Pin1 could interact with EGFP, which is 
an immuno-tag extrinsic to Nurr1, and therefore pulled down Nurr1 indirectly. All 
these results indicate that Pin1 interacts with Nurr1 physically as expected. On the 
other hand, the bio-information searches also implicated the potential interaction 
between Nurr1 and Pin1, because Nurr1 has Ser/Thr-Pro motif which is a specific 
Pin1 recognizing and catalyzing motif.  
To further confirm the above results, another set of co-immunoprecipitation assay 
was carried out using Nurr1 antibody to address the question of whether Nurr1 can 
pull down Pin1 in vitro. To this aim, SH-SY5Y cells were co-transfected with 
pCMX-Nurr1 and pcDNA-Pin1-GFP or transfected with pcDNA-Pin1-GFP or a 
vector expressing GFP tag. Proteins were extracted in a buffer containing 1% protease 
inhibitor and boiled in order to block degradation of proteins. Extracts were 
subsequently analyzed by immunoblotting using antibody against GFP. Results 
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depicted in Figure 4.13 B right penal show that exogenous Pin1 tagged with GFP is 
expressed in transfected SH-SY5Y cells. The same extracts were then 
immunoprecipitated using a polyclonal rabbit Nurr1 specific antibody and analyzed 
using a mouse antibody against GFP-tag. The obtained results (Figure 4.13 B, left 
panel) indicate that the immuno-complex, which was immunoprecipitated by the 
agarose beads conjugated with a polyclonal rabbit anti-Nurr1 antibody, performed a 
Nurr1 pull-down assay. The obtained pull-down samples were analyzed by 
immunoblotting using GFP specific antibody. As expected, GFP tagged Pin1 was 
detected in lane 2 and lane 3 (Figure 4.13 B, left panel, 55 kDa corresponding to 
GFP-Pin1). The EGFP-Nurr1 fusion protein was detected as a 100 kDa band, 
indicating that it is anti-Nurr1 antibody that was performing the pull-down assay. 
Therefore, this result confirms the specific physical interaction between Nurr1 and 
Pin1 via anti-Nurr1 antibody (Figure 4.13 B, left panel, upper bands). There is no 
band corresponding to the 35 kDa GFP protein, indicating that Nurr1 does not interact 
with GFP directly and deciphering the physical interaction between Nurr1 and Pin1 
themselves. Moreover, only the 35 kDa and 55 kDa bands, corresponding to GFP and 
GFP-Pin1, respectively, were shown in lane 4, and this is to further ascertain the 
specificity of the mouse antibody again GFP applied in the above immunoblotting 
assays.  
All in all, these co-immunoprecipitation experiments were carried out to verify 
that Nurr1 and Pin1 interact with each other physically in vitro. The present study 
provides the first demonstration on the direct interaction between Nurr1 and Pin1. It is 
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still remained unclear that via what mechanisms these two proteins cooperate together. 
In future, some biochemical assays including truncation and mutagenesis assays could 
be carried out to further explore the details about the interaction between Nurr1 and 
Pin1. However, it could be speculated here that, Pin1 interacts with and recognizes 
Nurr1 as its substrate via Ser/Thr-Pro motifs within the Nurr1 protein. On the other 
hand, from the recent literature (Codina et al., 2004), the structural studies of the 
C-terminal ligand-binding domain (LBD) of Nurr1 countered the previous knowledge 
regarding Nurr1 as a ligand-free receptor. Rather, the hydrophobic groove buried in 
the C-terminal of Nurr1 LBD is prone to facilitate the recruitment of potential 
co-factors. Consequently, Pin1 might be such a co-factor regarding their physical 
interaction via Nurr1 LBD. Therefore, the studies of Nurr1 together with Pin1 are still 
at the very early stages and future work will be explored more about this. 
 
4.2.7.3 Pin1 blocks Nurr1 expression in NT2 cells, however, in the presence of 
retinoic acid, Pin1 is not down-regulated in Nurr1-over-expressed NT2 cells 
To begin elucidating the significance of the observed protein-protein interaction 
between Nurr1 and Pin1, the influence of Pin1 in the Nurr1-induced neuronal 
progenitor cell differentiation was further studied. 
As shown in Figure 4.14 A, Nurr1 was markedly up-regulated after 16 days of 
exposure to retinoic acid in mock-treated NT2 cells. Whereas even though Nurr1 was 
slightly up-regulated at the early stages of the differentiation of Pin1-over-expressed 
NT2 cells, the expression level of Nurr1 was decreased at the late stages of 
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development. Interestingly, in mock-treated differentiating NT2 cells, the expression 
level of Pin1 was gradually increased.  Consistently, in mock-treated differentiating 
NT2 cells, the expression of Nurr1 was also gradually increased. However, the level 
of Pin1 in Nurr1-over-expressed NT2 cells was not increased; rather, especially at the 
late stages of development, it was decreased slightly.  
These phenomena together with the previous co-immunoprecipitation results 
aroused the following considerations: 
How does Pin1 block Nurr1 expression in differentiating NT2 cells? Is it related 
to signaling pathway(s) induced by retinoic acid? Via what mechanism does Pin1 play 
a negative-regulation role in this process? 
To access the existent mechanism and address the above questions, further 
experiments were carried out as described below. 
 
4.2.7.4 Pin1 interacts with retinoic acid receptor alpha (RARα) and retinoid X 
receptor (RXR) 
The mechanism whereby Nurr1 promotes dopaminergic neuron differentiation 
has remained unknown, and the only Nurr1 target gene identified to date in 
developing DA cells is tyrosine hydroxylase (TH), the rate-limiting enzyme in DA 
synthesis. Similar to other nuclear receptors, Nurr1 recognizes DNA by binding 
hormone-response elements (HREs) in the promoters of regulated target genes (Maira 
et al., 1999). In case of Nurr1, several such binding sites have been identified (Maira 
et al., 1999). The DNA sequence determines the type of protein complex interacting 
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with the HRE. Accordingly, Nurr1 can bind as a monomer and activate transcription 
from a particular HRE referred to as NGFI-B-response element (NBRE). Moreover, 
Nurr1 trans-activation through the NBRE is mainly dependent on an activation 
function localized in the large amino-terminal domain of the receptor. In addition, in 
certain cell lines, Nurr1 activity can also be mediated in part by an activation function 
within its putative carboxyl-terminal ligand-binding domain (LBD) (Castro et al., 
1999). However, it remains unclear if endogenous ligands exist or if Nurr1 exerts its 
functions in the absence of ligands. Actually, it is well documented that Nurr1 can 
form heterodimers with the retinoid X receptor (RXR) and bind to certain retinoic 
acid-responsive elements (Perlmann et al., 1995; Forman et al., 1995). 
Given a short summary about retinoic acid-induced cell differentiation here, it is 
much easier to understand the following assays carried out to study the potential role 
of Pin1 in this signaling pathway. Retinoids are potent inducers of cell differentiation 
in a variety of tissues in vivo as well as in many different cell lines cultured in vitro. 
Two types of retinoid receptors, retinoic acid receptor (RAR) and RXR (retinoic X 
receptor), mediate the effects of retinoids. RAR binds all-trans and 9-cis-RA, whereas 
RXR binds only 9-cis-RA. RXR forms heterodimers with RAR and with a number of 
other nuclear receptors including Nurr1 and NGFI-B. Whereas RXR is an inactive 
partner in complex with several other nuclear receptors, RXR can be very efficiently 
activated by its ligand in complex with Nurr1 or NGFI-B, suggesting that one 
function of these orphan receptors might be to promote ligand-induced signaling by 
RXR in vivo (Perlmann et al., 1995; Forman et al., 1995). 
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From the above information as well as the previous experimental results, it was 
hypothesized that Pin1 might regulate or interact with RARα and/or RXR in NT2 
differentiating NT2 cells exposed to retinoic acid. First, the cell extracts with Nurr1 or 
Pin1 over-expression or mock transfection were subsequently analyzed by 
immunoblotting. Second, the cell extracts with Pin1 over-expression were subjected 
to co-immunoprecipitation assay to test whether Pin1 would pull down endogenous 
RXRα and RARα.  
Figure 4.15 A shows that the expression levels of in Nurr1-overexpressing NT2 
cells were markedly increased compared to those in mock-treated cells; whereas the 
levels of RARα were constantly diminished in Pin1-over-expressed NT2 cells. The 
same trends of expression levels of RXRα were observed in Nurr1-over-expressed, 
Pin1-over-expressed, or mock-treated NT2 cells. These data indicated that Pin1 was 
really involved in regulating RXRα together with RARα in the neuronal progenitor cell 
differentiation process.  
To address the question of whether Pin1 can directly interact with RXRα or RARα 
, the co-immunoprecipitation assays were performed and the results were 
demonstrated in Figure 4.15 C. SH-SY5Y cells were transfected with GFP-Pin1 or a 
vector expressing a GFP tag. Extracts were subsequently analyzed by immunoblotting 
using antibody against RARα or RXRα respectively. Results depicted as input show 
that the endogenous RARα or RXR was detected by the specific antibodies 
respectively as a 50 kDa band in the input lanes (Figure 4.15 C, lane1 and lane 4), 
respectively. The same extracts were immunoprecipitated using polyclonal rabbit 
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RARα or RXRα specific antibodies. The immune complexes were then examined by 
immunoblotting using a mouse antibody against GFP-tag. As expected, the antibody 
against GFP recognized a 55 kDa band (Figure 4.15 C, lane 2 and lane 3), which is 
corresponding to GFP-Pin1 fusion protein, in the protein samples associated to the 
agarose beads conjugated with RARα or RXRα. However, the antibody against GFP 
did not recognize a 35kDa band corresponding to GFP-tag in the mock-treated cell 
extracts in either RARα or RXRα pull-down immune complex. It indicated that GFP 
did not interact with RARα or RXRα. Consistently, the obtained 55kDa band 
representing GFP-Pin1 fusion protein was only pulled down by RARα or RXRα 
respectively.  
As reported elsewhere, Pin1 interacts with RARα and induces its degradation 
(Brondani et al., 2005). Moreover, RAR forms heterodimers with RXR; and, Nurr1 
also forms heterodimers with RXR and binds to certain retinoic acid-responsive 
elements. It was speculated here that Pin1might block the downstream signaling 
pathways of Nurr1 in dopamine neuron development by disrupting the co-regulator 
recruitment activity of Nurr1, resulting in the further blockage of retinoid-induced 
signal transduction in cell differentiation. According to what was reported by 
Brondani V. et al. (2005), only the phosphorylated RARα  is destabilized upon Pin1 
co-transfection. However, due to the limited resources available in the current project, 
the characteristics of interaction between Nurr1 and Pin1 were not elucidated in this 
work. The following questions still remain to be addressed later. First, whether the 
interaction between RARα / RXRα and Pin1 associated to the phosphorylation is via 
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cell type manner? Second, the down-regulation of RARα  and RXRα is related to 
phosphorylation or via other mechanisms such as ubiquitin-mediated proteasome 
degradation? Third, since members of retinoic acid receptor family has highly 
conserved ligand-binding domains (LBDs), whether the interaction between Pin1 and 

































Figure 4.1 All-trans retinoic acid treatments of NT2/D1 cells.  
Treatment of NT2/D1 cells with 10 µM all-trans retinoic acid (atRA) for different 
time courses: (A) Phase-contrast image of NT2/D1 cells; (B) Phase-contrast image of 
NT2 cells treated with RA for 5 days; (C) Phase-contrast image of NT2 cells treated 
with RA for 10 days; (D) Phase-contrast image of NT2 cells treated with RA for 16 
days; (E) Phase-contrast image of NT2 cells treated with RA for 22 days; (F) 
Phase-contrast image of NT2 cells treated with RA for 30 days.  


















EGFP-Nurr1       Phase-contrast       Merge 
 












































GFP-Pin1          Phase-contrast        Merge 
 










b. NT2 (10 d) 
   





   
c. NT2 (22 d) 
    






d. NT2 (30 d) 



















































Figure 4.2 Fluorescent detection of Nurr1 or Pin1 in retinoic acid treated 
differentiating NT2 cells.  
Transfection of endogenous Nurr1 or Pin1 in RA treated NT2 cells according to 
different time courses. (A) Left column of panels: GFP-tagged Nurr1 over-expression 
in NT2/D1 cells and NT2 differentiating cells at different stages; middle column of 
panels: phase-contrast micrograph of NT2/D1 cells and NT2 differentiating cells at 
different stages; right column of panels: merged GFP-tagged Nurr1 with 
phase-contrast micrograph of NT2/D1 cells and NT2 differentiating cells at different 
stages. Scale bar: a—c, 100 µm; d, 20 µm; (B) left column of panels: GFP-tagged 
Pin1 over-expression in NT2/D1 cells and NT2 differentiating cells at different stages; 
middle column of panels: phase-contrast micrograph in NT2/D1 cells and NT2 
differentiating cells at different stages; right column of panels: merged GFP-tagged 
Nurr1 with phase-contrast micrograph of NT2/D1 cells and NT2 differentiating cells 
at different stages. Scale bar: a, 100 µm; b—d, 20 µm; (C) The graphs show 
percentage of differentiating NT2 cells with Nurr1-overexpressing (green), 
Pin1-overexpressing (blue) or mock transfection (red) after exposed to retinoic acid 3 
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Figure 4.3 Over-expression of Nurr1 induces growth arrest (at G1 phase) in 
NT2 cells, whereas over-expression of Pin1 promotes mitotic growth (S and G2, 
M phase) in NT2 cells.  
RA treated differentiating NT2 cells were transfected with EGFP or Nurr1 expression 
vectors according to different time courses (5 d, 10 d, 16 d, 22 d and 30 d) of RA 
induction, harvested 48 h post-transfection, and analyzed by FACS. (A) Left panel: 
mock transfection in NT2 cells with RA for different time courses; middle panel: 
Nurr1 over-expression in NT2 cells with RA for different time courses; right panel: 
Pin1 over-expression in NT2 cells with RA for different time courses. Transfected 
cells were sorted by EGFP/GFP expression, and their distribution in different phases 
of cell cycle was determined by quantification of DNA by measuring the extent 
propidium iodide staining (see Chapter II Methodology). (B) The percentage of 
transfected cells distributed in the G0, G1, S and G2/M phases of cell cycle are 
calculated respectively. Data represent the mean ± SE from three independent 
experiments (* p< 0.05).  
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Figure 4.5 Cell cycle regulation proteins expression pattern in Nurr1/Pin1 
over-expressed NT2 cells.  
(A) Panel a: CyclinD1 expression in Nurr1 over-expressing NT2 cells; panel b: Cdk6 
expression in Nurr1 over-expressed NT2 cells; panel c: CyclinB1 expression in Nurr1 
over-expressing NT2 cells; panel d: actin (B) panel a: CyclinD1 expression in Pin1 
over-expressed NT2 cells; panel b: Cdk6 expression in Pin1 over-expressed NT2 cells; 
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Figure 4.6 Immunocytochemical analyses of dopaminergic neuron marker- 
dopamine transporter (DAT) in Nurr1 or Pin1 over-expression NT2 cells.  
(A) At the indicated times, cells were transfected with EGFP-Nurr1 vector and 
immunoassayed with anti-DAT antibody to detect the endogenous expression of DAT. 
Rows of the panels (from left to right): phase-contrast, EGFP-Nurr1, DAT labeled by 
anti-DAT antibody and the merged photos of the above three images. (B) At the 
indicated times, cells were transfected with GFP-Pin1 vector and immunoassayed 
with anti-DAT antibody to detect the endogenous expression of DAT. x Scale bar: 20 
µm. Rows of the panels (from left to right): phase-contrast, GFP-Pin1, DAT labeled 





















                                                    
                                                    
                                                    
                                                    
                                                    
                                                    






















































































Figure 4.7 Expression of endogenous dopamine transporter (DAT) in 
Nurr1-overexpressing or Pin1-overexpressing NT2 cells.  
(A) At the indicated times, cells were transfected with a Nurr1 expression or an empty 
vector. The number of differentiated DAT-positive cells was counted 2 days after 
transfection. (B) At the indicated times, cells were transfected with a Pin1 expression 
or an empty vector. The number of differentiated DAT-positive cells was counted 2 
days after transfection. Average values of triplicates are shown. Error bars represent 
standard deviation. The number of non-transfected NT2 cells exposed to retinoic acid 
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Figure 4.8 Immunocytochemical analyses of dopaminergic neuron marker- 
tyrosine hydroxylase (TH) in Nurr1 or Pin1 over-expressed NT2 cells.  
(A) At the indicated times, cells were transfected with EGFP-Nurr1 vector and 
immunoassayed with anti-TH antibody to detect the endogenous expression of TH. 
Rows of the panels (from left to right): phase-contrast, EGFP-Nurr1, TH labeled by 
anti-TH antibody and the merged photos of the above three images. (B) At the 
indicated times, cells were transfected with GFP-Pin1 vector and immunoassayed 
with anti-TH antibody to detect the endogenous expression of TH. Rows of the panels 
(from left to right): phase-contrast, GFP-Pin1, TH labeled by anti-TH antibody and 





















                                                    
                                                    
                                                    
                                                    
                                                    
                                                    






























































































Figure 4.9  Expression of endogenous tyrosine hydroxylase (TH) in 
Nurr1-over-expressed or Pin1-over-expressed NT2 cells.  
(A) At the indicated times, cells were transfected with a Nurr1 expression or an empty 
vector. The number of differentiated TH-positive cells was counted 2 days after 
transfection. (B) At the indicated times, cells were transfected with a Pin1 expression 
or an empty vector. The number of differentiated TH-positive cells was counted 2 
days after transfection. Average values of triplicates are shown. Error bars represent 
standard deviation. The number of non-transfected NT2 cells exposed to retinoic acid 
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Figure 4.10 Immunoblotting analyses of dopaminergic neuron markers in 
differentiating NT2 cells. NT2 cells were transfected with an empty expression 
vector or a vector encoding Nurr1 or Pin1.  
Cell extracts were subjected to immunoblotting to detect the expression patterns of 
tyrosine hydroxylase (TH), dopamine transporter (DAT), dopamine receptor 2 (D2DR) 
respectively. (A) The expression pattern of TH was detected in Nurr1-over-expressed 
(a), Pin1-over-expressed (b) or mock transfected (c) NT2 cells. (B) The expression 
pattern of DAT was detected in Nurr1- over-expressed (a), Pin1-over-expressed (b) or 
mock transfected (c) NT2 cells. (C) The expression pattern of TH was detected in 
Nurr1-over-expressed (a), Pin1-over-expressed (b), Pin1-over-expressed (b) or mock 
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Figure 4.11 Immunoblotting analysis (A-C) and immunocytochemical 
detection (D) of phosphorylated tyrosine hydroxylase (phosphor-TH) expression 
in Nurr1/Pin1 over-expressed NT2 cells.  
Aggregated NT2 cells were treated with RA for 5, 10, 16, 22, 30 and 35 days as 
described in Methods. The aggregates were then replated on culture plates and 
maintained for 4-6 hrs in the absence of RA when transfected with foreign genes and 
incubated with transfection reagent before fresh medium was replenished. (A) Upper 
panel: phosphor-TH in Nurr1 over-expressed NT2 cells; lower panel: actin; (B) Upper 
panel: phosphor-TH in Pin1 over-expressed NT2 cells; lower panel: actin; (C) Upper 
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Figure 4.12 Immunofluorescent detection of sub-cellular co-localization of 
Nurr1 and Pin1.  
NT2 cells were transfected at indicated times-5 d (A), 16 d (B) and 22 d (C) 
respectively, with a GFP-Pin1 expression vector and immunoassayed with anti-Nurr1 
antibody to detect the endogenously expressed Nurr1. Phase micrograph (a), 
immunofluorescent micrograph of exogenous Pin1 (b), Phase micrograph (c), 
endogenous Nurr1 staining and merged with phase micrograph, (d) exogenous Pin1 
and endogenous Nurr1 of differentiating NT2 cells. Rows of the panels (from left to 
right): phase-contrast, GFP-Pin1, Nurr1 labeled by anti-Nurr1 antibody and the 
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Figure 4.14 Pin1 blocks Nurr1 expression in NT2 cells, whereas Pin1 is 
unregulated in retinoic acid induced NT2 cells.  
NT2 cells were transfected with empty expression vector, expression vectors 
encoding EGFP-Nurr1, or GFP-Pin1. (A) At indicated times, cells were transfected 
with GFP-Pin1 expression vector or an empty vector. Cell extracts were analyzed by 
immunoblotting with Nurr1 antibody: panel (a) demonstrated the expression pattern 
of Nurr1 in NT2 cells exposed to retinoic acid with mock transfection; panel (b) 
showed the behavior of Nurr1 in Pin1-over-expressed NT2 cells. 
(B) At indicated times, cells were transfected with EGFP-Nurr1 expression vector or 
an empty vector. Cell extracts were analyzed by immunoblotting with Pin1 antibody: 
panel (c) demonstrated the expression pattern of Pin1 in NT2 cells exposed to retinoic 
acid with mock transfection; and panel (d) showed the Pin1 behavior in 






5d  10d  16d  22d  30d  35d           5d  10d  16d  22d  30d  35d 
 
A. RARα in NT2 cells 
 








(c) Pin1 over-expression 
                                    







B.  RXRα in NT2 cells 

























C. SH-SY5Y cells 
                                         
                                                                          
                       
Input IP RARα Input 
 
55 KD 50 KD
 
 50 KD 
 
 




Figure 4.15 Pin1 and Nurr1 cooperate in retinoic acid-
differentiation by blocking or inducing the expression of ret
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5.1. General discussion 
5.1.1. Neuronal progenitor cell model and relevant transcriptional 
regulation 
Neuronal progenitor cell-NT2/D1 has been used as a cell model to characterize 
the functions of transcription factor-Nurr1 and mitotic regulator-Pin1 during neuron 
development. With the large-scale mutagenesis approach, functional screening, 
genome research and cloning efforts, the neuronal progenitor cells have provided a 
wealth of information for vertebrate neuron developmental studies. Mature 
mammalian neurons are incapable of cell division and cannot, with the exception of 
olfactory neurons, be generated from stem cells in the adult nervous system. Thus, 
continuously dividing clonal cell lines with neuronal characteristics have proven to be 
very useful to investigators studying almost every aspect of the nervous system. Such 
cell lines allow the generation of large numbers of homogeneous cells and the 
manipulation of these cells through gene transfer to yield novel derivatives expressing 
foreign gene products (Lendahl and McKay, 1990). To be useful, it is important that a 
cell line have a short doubling time so that it is possible to accumulate enough cells 
for biochemical studies. However, the more rapidly a cell line proceeds through the 
cell cycle, the fewer features it has in common with neurons. The likely reason for 
this is that many differentiated properties of neurons are not fully articulated in vivo 
until they become postmitotic (Temple 1990).  
The ideal cell line for analysis of the processes of neuronal maturation and the 
intrinsic factors that affect the establishment of the neuronal phenotype would be one 
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that divides rapidly so that it could be grown in large quantities and transfected to 
produce a stable population of cells expression exogenous gene products. Upon 
induction with an agent promoting differentiation, this ideal cell line would leave the 
cell cycle, undergo an irreversible commitment to a neuronal phenotype, and exist in a 
stable postmitotic state. These cells would subsequently elaborate extensive neuritic 
processes and would mature to a state similar to that of primary neurons in culture.  
Embryonic carcinoma cell lines satisfy some of the above criteria. These cells, 
which have been derived from both murine and human embryonic tumors, consist of 
undifferentiated multi-potential cells that will differentiate into one or several cell 
types when placed under certain conditions (usually including treatment with retinoic 
acid). This process resembles the actual commitment to different phenotypes that are 
found in vivo (Pfeiffer et al., 1981). NTera 2/D1 (NT2), a human teratocarcinoma cell 
line, has characteristics in common with its murine counterparts in that these cells are 
capable of undergoing phenotypic changes in response to RA. However, unlike most 
of the murine embryonic carcinoma cell lines, the only identifiable differentiated 
phenotype found following RA treatment of NT2 cells is the neuron (Andrews 1984). 
In all previous studies, these neurons represented a small percentage of the cells, and 
they coexisted with a population of unidentified large flat cells and a residual number 
of undifferentiated stem cells (Andrews 1984).  
The study here mainly reasoned that it would be desirable to obtain nearly pure 
neuronal cultures from RA-treated NT2 cells. To this end, I have used retinoic acid 
and transient transfection techniques (including differential attachment and treatment 
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with mitotic inhibitors) to obtain highly purified populations of human neurons from 
NT2 cells. Before exposure to RA, these mitotically active NT2 cells express several 
markers typical for neural epithelial cells and neural progenitors committed to 
neuronal cell fate, including neuroepithelial intermediate filaments keratin and nestin 
(Lee et al., 1986; Pleasure et al., 1992), cell adhesion molecules NCAM and 
N-cadherin (Pleasure et al., 1992), epithelial cell surface antigen AUA1 and 
stage-specific embryonic antigen-3 (SSEA-3) (Andrews et al., 1984). After exposure 
to RA and mitotic inhibitors, these NT2 cells differentiate into post-mitotic 
neuron-like cells resembling committed CNS neuronal precursors (Pleasure et al., 
1992). In this study, I only detected immunocytochemically the typical dopaminergic 
markers of ventral midbrain neurons, including tyrosine hydroxylase (TH), dopamine 
transporter (DAT and dopamine receptor type 2 (D2DR), and sought to examine the 
expression pattern of the above dopaminergic neuron markers. These neurons (NT2/N 
cells) express all ubiquitous neuronal markers that can be identified as axons or 
dendrites using molecular and functional criteria. Finally, I have also shown that 
undifferentiated NT2 cells can be transiently transfected and that the NT2/N cells 
continue to differentiate with retinoic acid treatment, but NT2/N cells have different 
behaviors after transfected with various exogenous gene products. 
Regarding the transcriptional regulation events underlying NT2 cell 
differentiation, there would be several aspects need to be highlighted as bellows: 
Since the NT2/D1 cell is a cloned embryonal cancer cell line that differentiates 
into a neuronal phenotype and other cellular lineages after treatment with retinoic acid, 
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it is significant to address the underlying mechanisms by which the different cellular 
lineages are regulated and determined. Initially, Miller et al. (Miller et al., 1990) once 
examined the regulated expression of growth factors and proto-oncogenes in NT2/D1 
cells. They found three growth factors including Hst-1/kFGF, TGF-alpha and bFGF 
and minimal decline was seen for c-myc, N-myc, c-fos and c-myb. While, increased 
expression with differentiation was seen for the human homeotic genes Hox 2.1 and 
Hox 2.2. They demonstrated after 6 days of RA treatment in NT2 cells that the 
down-regulation of growth factors inversely correlated with the homeotic gene 
up-regulation. Then, people turned to study the cellular lineage determination by 
further studying the cell cycle events. Spinella et al. (Spinella et al., 1999) 
demonstrated that retinoids promote ubiquitination and degradation of cyclin D1 
during retinoid-induced differentiation of NT2/D1 cells. They found that in response 
to all-trans-retinoic acid (RA) treatment, the human embryonal carcinoma cell line 
NT2/D1 exhibits a progressive decline in cyclin D1 expression beginning when the 
cells are committed to differentiate, but before onset of terminal neuronal 
differentiation. And they believed that the decrease in cyclin D1 protein is tightly 
associated with the accumulation of hypo-phosphorylated forms of the retinoblastoma 
protein and G (1) arrest via proteasome degradation. Taken together, these findings 
strongly implicate RA-mediated degradation of cyclin D1 as a means of coupling 
induced differentiation and cell cycle control of human embryonal carcinoma cells. 
In addition, it is worthwhile to address the contribution of specific retinoic 
receptors during RA-mediated differentiation and growth suppression of human 
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embryonic carcinoma cells. As introduced elsewhere, the pleiotropic effects of RA are 
mediated by retinoic acid receptors (RARs) and retinoid X receptors (RXRs), 
members of the nuclear receptor family of transcription factors. Spinella et al. 
(Spinella et al., 1998) once demonstrated that RARγ over-expression in NT2/D1 cells 
signals mesenchymal NT2/D1 terminal differentiation while RARalpha and RARbeta 
do not and RARγ overcomes retinoid resistance in an NT2/D1 clone (NT2/D1-RI) 
having deregulated RARγ expression. Further, they highlighted RXRβ as playing an 
important role along with RARγ in signaling differentiation of NT2/D1 cells. 
Therefore, these findings reveal specific retinoid receptors must cooperate to signal 
terminal growth suppression and maturation of NT2/D1 cells. Additionally, Curtin et 
al. (Curtin et al., 2001) indicated that RA activates the intrinsic activation function of 
p53 by a novel mechanism independent of effects on p53 stability or DNA binding 
and that this activation may be a general mechanism that contributes to RA-mediated 
G1 arrest. Moreover, this activity was absent in retinoic acid receptor gamma 
(RARγ)-deficient NT2/D1-R1 cells but can be restored upon co-transfection with 
specific RARs (Curtin et al., 2001).  
In summary, taken together, the information generated from above on the cells is 
invaluable in understanding human neuron development and also can be used in cell 
therapy and transplantation in medical treatment of neurological disorders caused by 
neuron degeneration. 
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5.1.2. Transcription factor-Nurr1 in progenitor neuron 
differentiation 
Nurr1 is a transcription factor that belongs to the thyroid hormone/retinoic acid 
nuclear receptor super-family. With regard to the function of Nurr1 in brain 
development, deletion of the Nurr1 gene results in the loss of ventral midbrain DA 
neurons by their time of birth, at embryonic day 11.5 (Zetterstrom et. al., 1997). Of 
interest, DA neurons in other brain regions are born and develop normally, indicating 
that ventral midbrain DA neurons are specifically lost (Saucedo-Cardenas, et. al., 
1998; Castillo et al., 1998). These reports demonstrated that Nurr1 is required for the 
birth of DA neurons and led many investigators to examine whether Nurr1 was also 
sufficient to induce a DA phenotype. Overexpression of Nurr1 in a neural stem cell 
line (c17.2), which does not spontaneously generate TH-positive cells, resulted in 
cells that upon removal of mitogens predominantly differentiated into neurons, but 
less than 1% were TH-positive (Wagner et al., 1999). Notably, other 
Nurr1-overexpressed neural stem cells or embryonic stem cells give rise to glial cells 
that could then inadvertently participate in the differentiation of DA precursor’s in 
vitro (Kim et al., 2002; Sakurada et al., 1999). One candidate survival signal derived 
from glial cells could be docosahexaenoic acid (DHA), a ligand for the retinoic X 
receptor (RXR)-Nurr1 heterodimers that has recently been reported to promote the 
survival of newborn DA neurons (Wallen-Mackenzie et al., 2003). Regardless of 
whether DHA is the ligand for the RXR-Nurr1 heterodimers in the ventral 
mesencephalic, it is clear that endogenous ligands that work on the RXR-Nurr1 
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heterodimers exist in vivo. Indeed, reporting activity has been detected in the VM of 
dimerization-competent Nurr1-Gal4 transgenic mice, but not in 
Dimerization-deficient Nurr1-Gal4 mice, indicating that RXR-Nurr1 dimerization is 
necessary for transactivation in vivo (Wallen. et al., 2003). Interestingly, both RXR 
agonists and retinoic acid receptor (RAR) antagonists increased the survival of DA 
neurons in vitro, suggesting that the balance between RXR and RAR controls the 
survival of midbrain DA neurons. In agreement with a key role of RXR ligands in the 
development of DA neurons, Wagner et al. (1999) have previously reported that RXR 
agonists can enhance the DA differentiation of Nurr1-overexpressing neural stem 
cells. Thus, combined with other literature report, it is suggested that retinoids play a 
key role in the development of midbrain DA neurons by possibly promoting the 
differentiation of DA precursors and enhancing the survival of DA neurons. 
 
5.1.3. The prolyl isomerase-Pin1 in progenitor neuron differentiation 
The prolyl isomerase Pin1 is a conserved isomerase that is diversely involved in 
various biological processes and pathological conditions. Regarding its cis-trans 
catalyzing abilities, Pin1 can have profound effects on phosphorylation signaling. The 
structural and functional differences that resulted from cis-trans isomerization of 
specific pSer/Thr-Pro motifs probably underlie most Pin1-regulated/dependent events 
(Wulf et al., 2005). Therefore, phosphorylation-dependent protein interaction by Pin1 
remains a unique mode for the modulation of signal transduction in cell 
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differentiation/proliferation, especially involving cell cycle regulation. Here, I provide 
a probable aspect of regulatory event which indicates that Pin1, under a particular 
biological process/environment, would play a unique role in neuron development.    
The successful isolation of the human Pin1 cDNA sequences using the primers 
specific for its coding sequence from neuroblastoma cells, is a reflection of its 
remarkable expression ubiquitously in neurons. This is in view of the fact that Pin1 
may have its unique functions in neurons other than in cancer cells; however, it is 
unclear how Pin1 will play a positive or negative role in neurons. The present study 
described here was to explore the function of Pin1 in neuronal cell differentiation or 
neuron development together with Nurr1, which is an important gene in dopaminergic 
neuron development; and the standard functions of Nurr1 have been characterized 
else where (Castro et al., 2001; Hermanson et al., 2003 and Perlmann et al., 2005). 
It is interesting to find that Pin1 and Nurr1 have reverse influences regarding to 
neuronal cell differentiation. In summary, Nurr1 arrested neuronal progenitor cells in 
G1 phase and thereby they were terminally differentiating into CNS cells, whereas 
Pin1 promoted them to process mitotic proliferation even under the treatment with 
retinoic acid, which is an external factor to drive cell differentiation. Further 
experiments show that Pin1 interacts with RXR and RAR, which are nuclear receptors 
and homologous to each other. My findings are of importance since it was reported 
previously that Nurr1 can form heterodimers with RXR to furnish the signaling 
transduction of cell differentiation (Wallen-Mackenzie et al., 2003); also, a recent 
literature report has found that Pin1 interacts with RAR in vitro (Brondani et al., 
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2005). In view of all these and together with the experimental results presented here, I 
hereby speculate that Pin1 blocks the downstream signaling pathways of RA-induced 
dopaminergic neuron development by disrupting the co-factor recruitment activities 
of Nurr1, resulting in further blockage of Nurr1-related transcription events in the cell 
nucleus. To further verify my speculation, I propose future work to be on three 
aspects as described below.  
 
5.2. Future studies 
5.2.1. Identification of the interacting domains/motifs between Nurr1 
and Pin1 
In providing an initial analysis of the interaction between Nurr1 and Pin1 in vitro, 
the present study lays the groundwork for more extensive investigation of these two 
proteins. Specifically, the interaction domains between these two proteins have 
remained unknown so far. From the database search at 
www.biobase.de/cgi-bin/pub/databases/transfac, Nurr1 is found to have two 
proline-rich regions, which are between amino acid 127 to 233 and 346 to 391, 
respectively. Further, these two proline-rich regions contain several 
serine/threonine-proline motifs, which can potentially be phosphorylated and 
recognized by Pin1. Therefore, Pin1 might isomerize the conformation of Nurr1, or 
even to modulate Nurr1 expression and function in neuron development. It only can 
be speculated from the present co-immunoprecipitation assay that the 
serine/threonine-proline motifs in Nurr1 would be phosphorylated when the 
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interaction between Nurr1 and Pin1 occurs. However, more experiments are needed to 
explore the detailed interaction domains/motifs between Nurr1 and Pin1. For example, 
the mutagenesis and truncation of various regions within Nurr1 potential for 
interacting with Pin1 can be generated and then subjected to Co-IP analysis. The 
following questions can then be addressed: 
(a) whether the S/T-P motifs within Nurr1 are phosphorylated? 
(b) if the answer regarding the above question is positive, what are the individual 
interaction motifs between Nurr1 and Pin1? 
(c) whether the interaction pattern between Nurr1 and Pin1 is cell-type dependent 
or independent? 
(d) what is the further influence of Pin1 on Nurr1 expression in neuron 
development; in another word, it is unclear whether Pin1 will drive neuronal cells into 
what kind of fate eventually via interacting with Nurr1?  
I hypothesize that the clarification of mechanisms resides in the interaction 
between Nurr1 and Pin1. 
  
5.2.2. Elucidation of the downstream signaling pathways of Nurr1 in 
neuron development 
Several gene inactivation studies have established that Nurr1 is essential for 
development of midbrain DA neurons. These and the subsequent analyses of Nurr1-/- 
mice demonstrated that Nurr1 is required for later stages of DA neuron differentiation 
instead of early neurogenesis (Zetterstrom et al., 1997; Wallen et al., 1999). The 
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downstream signaling pathways of Nurr1-related development of neurons are still a 
mystery till nowadays. Despite extensive investigation during the last decades and so 
far, control mechanisms underlying the cell type-specific expression of the TH gene 
remains unclear. As it was reported else where, Nurr1 directly transactivates the 
promoter activity of the tyrosine hydroxylase gene in a cell-specific manner. It is 
supposed that the TH gene may be an immediate downstream target of Nurr1, 
regulating the transcriptional activity of the TH gene (Kim et al., 2003). Moreover, 
several other markers of midbrain DA neurons, e.g., aldehyde dehydrogenase 2, the 
homeobox transcription factors engrailed and Ptx3, were shown to be significantly 
down-regulated in the mutant mice, suggesting that Nurr1 may regulate the expression 
of multiple target genes. Consistent with previous studies elsewhere, exogenous 
expression of Nurr1 in neuronal cells resulted in up-regulation of known DA-specific 
marker genes including TH and DAT (Wallen et al., 1999; Hermanson et al., 2003). 
Precise mechanisms underlying regulation of these potential target genes by Nurr1 
require further investigation. One of these DA-specific genes, DAT, is responsible for 
termination of DA neurotransmission by rapid re-uptake to pre-synaptic nerve 
terminals. Recent cloning and characterization of the DAT gene promoter showed that 
DAT may be a target of Nurr1, suggesting the possibility that Nurr1 controls both 
DA-synthesizing and re-uptake genes (Sacchetti. et al., 1999; Bannon et al.,. 2002).  
It is speculated that Nurr1 will regulate more genes related to DA neuron 
development, and whether Nurr1 appears to require its DNA binding motif for 
activation of those downstream genes, or it can directly promote the transcription of 
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such genes remains unknown. Furthermore, it is also worthwhile to further explore the 
distinct functions of the activation function-1 (AF1) and the activation function-2 
(AF2) in N- and C-terminal of Nurr1, respectively (Steinmetz et al., 2001; Chawla et 
al., 2001), (Need to explain what are AF1 and AF2 and also cite the ref) regarding 
their potentials roles in cell type recognizing manner. 
 
5.2.3. Identification of potential co-factors of Nurr1 based on its 
unique structure and function in different environments 
The recent structural studies of Nurr1, especially from the results of NMR 
footprinting studies, have debuted that Nurr1 is not a ligand-free nuclear receptor as 
indicated previously (Codina et al., 2004). Actually, it was revealed that although 
Nurr1 shares classical ligand-binding domain architecture, they lack a ligand-binding 
cavity. This volume is instead filled with bulky hydrophobic side chains (Codina1. et 
al., 2004). Furthermore the “canonical” non-polar co-regulator binding groove is 
filled with polar side chains; thus, the regulation of transcription by this sub-family of 
nuclear receptor LBDs may be mediated by some other interaction surface on the 
LBD, reporting a novel co-regulator interface on the LBD of Nurr1. Also, in view of 
the studies presented here, Nurr1 and Pin1 interacted with each other physically. It is 
thus possible to speculate that the mechanisms; e.g. how Nurr1 recruits co-factors and 
interact with each other to promote neuron differentiation or storage DA cells under 
certain circumstances, or via the downstream signaling pathways to regulate other 
dopaminergic neuron markers such as TH and DAT. The detailed structural studies of 
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Nurr1 will drive us to further identify more Nurr1 co-regulators/co-factors regarding 
its neuron maintenance functions.  
 
Concluding remark 
In summary, the present study and the proposed future work aim to contribute to 
a greater understanding of Nurr1 together with Pin1 specifically in neuron 
development and thus towards unraveling the functional enigma of these genes which 
are important in the multi-cellular neuron system. This may contribute to their 
eventually utilization and involvement in genetic manipulation and pharmaceutical 
application, possibly with Nurr1 as a cell replacement targeting gene and Pin1 as a 
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